
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            NAD+ Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152550B48AF423030550B4000E92411E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cddis">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373823/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cell Death &amp; Disease">
<meta name="citation_title" content="NAD+ Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment">
<meta name="citation_author" content="Jiacheng Shen">
<meta name="citation_author_institution" content="Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China">
<meta name="citation_author" content="Fangfang Xu">
<meta name="citation_author_institution" content="Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China">
<meta name="citation_author" content="Tingwei Liu">
<meta name="citation_author_institution" content="Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China">
<meta name="citation_author" content="Yingjun Ye">
<meta name="citation_author_institution" content="Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China">
<meta name="citation_author" content="Shaohua Xu">
<meta name="citation_author_institution" content="Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="16">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="640">
<meta name="citation_doi" content="10.1038/s41419-025-07939-9">
<meta name="citation_pmid" content="40846839">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373823/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373823/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373823/pdf/41419_2025_Article_7939.pdf">
<meta name="description" content="The anti-tumor function of T cells in the ovarian cancer (OC) microenvironment influences the prognosis of OC. Previous studies have indicated that metabolic competition among microenvironmental cells regulates the function of immune cells. Recent ...">
<meta name="og:title" content="NAD+ Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The anti-tumor function of T cells in the ovarian cancer (OC) microenvironment influences the prognosis of OC. Previous studies have indicated that metabolic competition among microenvironmental cells regulates the function of immune cells. Recent ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373823/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373823">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41419-025-07939-9"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41419_2025_Article_7939.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373823%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373823/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373823/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373823/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cddis.gif" alt="Cell Death &amp; Disease logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cell Death &amp; Disease" title="Link to Cell Death &amp; Disease" shape="default" href="http://www.nature.com/cddis/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cell Death Dis</button></div>. 2025 Aug 23;16(1):640. doi: <a href="https://doi.org/10.1038/s41419-025-07939-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41419-025-07939-9</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell%20Death%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cell%20Death%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cell%20Death%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>NAD<sup>+</sup> Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jiacheng Shen</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jiacheng Shen</span></h3>
<div class="p">
<sup>1</sup>Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiacheng Shen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Fangfang Xu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Fangfang Xu</span></h3>
<div class="p">
<sup>1</sup>Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fangfang Xu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Tingwei Liu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Tingwei Liu</span></h3>
<div class="p">
<sup>1</sup>Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tingwei Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ye%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yingjun Ye</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yingjun Ye</span></h3>
<div class="p">
<sup>1</sup>Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ye%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yingjun Ye</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shaohua Xu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shaohua Xu</span></h3>
<div class="p">
<sup>1</sup>Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shaohua Xu</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092 China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 16; Revised 2025 Jul 9; Accepted 2025 Aug 3; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373823  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846839/" class="usa-link">40846839</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">The anti-tumor function of T cells in the ovarian cancer (OC) microenvironment influences the prognosis of OC. Previous studies have indicated that metabolic competition among microenvironmental cells regulates the function of immune cells. Recent research has shown that NAD<sup>+</sup> metabolism plays a significant role in modulating immune cell activity, and increasing NAD<sup>+</sup> levels is a promising therapeutic strategy to enhance the effector functions of immune cells. However, the regulatory mechanisms of NAD<sup>+</sup> metabolism on the anti-tumor function of T cells in the OC microenvironment remain unclear. This study found that exogenous supplementation of NAM to increase NAD<sup>+</sup> levels in T cells significantly activates the endogenous p-STING axis and downstream interferon signaling within T cells, thereby enhancing T cell activation and anti-tumor effects. Concurrently, we discovered that elevated NAD<sup>+</sup> levels promote the retention of STING on the Golgi apparatus. Mechanistically, we elucidated that the increase in NAD<sup>+</sup> levels mediated by NAM downregulates the expression of SURF4 protein through ubiquitination and degradation, subsequently activating the p-STING axis in T cells. Furthermore, exogenous NAM supplementation can further enhance the activation of the T cell STING axis by PARP inhibitor (PARPi)-treated OC cells, and the combination of PARPi and NAM significantly augments the anti-tumor function of T cells, inhibiting the progression of OC. Our findings provide a molecular basis for the regulation of T cell anti-tumor function by NAD<sup>+</sup>, highlighting the potential strategy of targeting T cell metabolic reprogramming for the treatment of OC.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Ovarian cancer, Cancer microenvironment</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Ovarian cancer (OC) remains a leading cause of cancer-related mortality due to its highly aggressive nature and propensity for recurrence [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Although current first-line chemotherapy regimens have improved patient outcomes to some extent, the majority of patients eventually develop drug resistance [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Furthermore, the low immune responsiveness of the OC microenvironment significantly impedes the efficacy of immunotherapies [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. The tumor immune microenvironment (TIME) of OC plays a pivotal role in tumor progression, immune evasion, and treatment resistance [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Despite existing research elucidating the complexity of OC TIME, our understanding of the regulatory factors governing the immune status in this microenvironment remains limited.</p>
<p id="Par3">T cells represent a crucial cellular component of anti-tumor immunity. In the OC microenvironment, the prevalent immunosuppressive milieu often constrains the antitumor efficacy of T cells [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. The functional activation of T cells is associated with the regulation of various endogenous signaling pathways. As a critical regulator of cancer immunity, the stimulator of interferon genes (STING) signaling pathway demonstrates a close relationship with cancer development [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Contrary to the prevailing view that this axis primarily bridges innate and adaptive immunity, increasing evidence suggests that adaptive immune cells can directly respond to STING engagement [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. In recent years, the functional role of STING signaling in T cells has garnered increasing attention, particularly in regulating T cell survival, differentiation, and immune suppression. Research indicates that many STING signaling functions in T cells may be independent of type I interferon [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. However, the role of endogenous STING signaling in T cell responses remains largely unexplored, and understanding the direct effects of STING pathway in T cells will facilitate the rational design of novel therapeutic strategies.</p>
<p id="Par4">Metabolism plays a significant role in the tumor microenvironment (TME), where metabolic competition among different cellular components regulates immune cell function [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. As a crucial aspect of cellular activities, NAD<sup>+</sup> metabolism has been suggested to play an important role in regulating immune cell activity [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. In this context, NAD<sup>+</sup> availability becomes a limiting resource, and the competition for NAD<sup>+</sup> between tumor cells and immune cells represents a key mechanism of tumor-mediated suppression of anti-tumor immunity. Immune cells, particularly T cells and macrophages, require NAD<sup>+</sup> to support their activation, proliferation, and effector functions [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Therefore, in-depth investigation of NAD<sup>+</sup> metabolism in the OC microenvironment and its regulatory mechanisms on endogenous signaling pathways in T cells is of great significance for exploring approaches to enhance T cell anti-tumor activity.</p>
<p id="Par5">This study reveals the existence of NAD<sup>+</sup> level competition between tumor cells and T cells in the OC microenvironment. Low NAD<sup>+</sup> levels in T cells suppress their anti-tumor function. Exogenous supplementation with the NAD<sup>+</sup> precursor NAM can significantly enhance T cell anti-tumor effects, mediated through STING axis activation. We explored potential mechanisms of NAD<sup>+</sup> level regulation of STING axis activity. Additionally, this study investigates the potential role of NAM supplementation in enhancing PARP inhibitor (PARPi)-mediated anti-tumor immunity by increasing T cell NAD<sup>+</sup> levels, providing a theoretical foundation for developing novel therapeutic approaches.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">OC single-cell data clustering and subpopulation identification</h3>
<p id="Par6">OC single-cell dataset <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217517" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE217517</a> was downloaded from GEO (<a href="https://www.ncbi.nlm.nih.gov/geo/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/geo/</a>) for investigating the intra-tumoral microenvironment [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. The ‘Seurat’ package was used for data normalization, dimensionality reduction, and clustering of single-cell data, with the RunTSNE function employed for dimensionality reduction and data visualization. Consistent with the methods we used in our previous research, we extracted malignant epithelial cells from the single-cell data using marker proteins WT1, PAX8, and MUC16, labeled as “Malignant”, while the remaining cells were labeled as “Non-malignant” (Fig. <a href="#Fig1" class="usa-link">1B</a>, Fig. S<a href="#MOESM1" class="usa-link">1D</a>) [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. NAMPT-mediated NAD<sup>+</sup> biosynthesis regulates T cell function in OC microenvironment.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373823_41419_2025_7939_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be32/12373823/219c0ab1c0bc/41419_2025_7939_Fig1_HTML.jpg" loading="lazy" id="d33e394" height="685" width="790" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> Dimensionality reduction, clustering, and cell annotation of single-cell data from OC (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217517" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE217517</a>). <strong>A</strong> A total of 28 cell clusters were identified, with each color representing a distinct cell cluster. <strong>B</strong> Discrimination between malignant and non-malignant cells, along with cell annotation. Six cell types were identified among the non-malignant cells, with each color denoting a specific cell type. <strong>C</strong> The NAD<sup>+</sup> content in T cells was found to be abnormally reduced during co-culture with OC cells. <strong>D</strong> Marker genes are used for the subtype identification of T cells. <strong>E</strong> T cell subsets can be clustered into five distinct cell types: HSC, NK cells, Mesangial cells, CD8<sup>+</sup> T-cells, CD4<sup>+</sup> T-cells. <strong>F</strong> The expression of the NAD<sup>+</sup> synthesis enzyme NAMPT is closely correlated with the expression of T cell activity genes. <strong>G</strong> NAMPT shows a positive correlation with T cell anti-tumor signaling. <strong>H</strong> Transcriptional level detection of NAMPT overexpression in T cells. <strong>I</strong> Overexpression of NAMPT increases the NAD<sup>+</sup> levels within T cells. <strong>J</strong> NAMPT promotes the expression of T cell chemotaxis receptors. <strong>K</strong>, <strong>L</strong> NAMPT enhances the expression of T cell anti-tumor factors IFNγ, GZMB and TNFα. <strong>M</strong>, <strong>N</strong> NAMPT upregulates the expression of T cell infiltration and activation markers (CD3D, CD69, and GZMB), while FK866 can effectively suppress T cell reactivation.</p></figcaption></figure><p id="Par7">The ‘SingleR’ package was utilized to identify cell types within the single-cell data. For the broad classification of cell types, the cell type annotation method from the HumanPrimaryCellAtlasData (HPCA) database within the ‘celldex’ package was employed. To further delineate functional subsets of T cell populations, the BlueprintEncodeData database from the ‘celldex’ package was applied. Visualization of the proportions of various cellular components across all samples was conducted using the ggplot function.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Differential expression genes (DEGs), functional enrichment, and protein-protein interaction analysis</h3>
<p id="Par8">The ‘limma’ package was used for differential gene screening, with DEGs identified based on filtering criteria: adj.p.value &lt; 0.05 and |Fold Change | &gt; 1.5.</p>
<p id="Par9">The ‘ClusterProfiler’ package was used to identify significantly enriched Gene Ontology (GO) terms and pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG), Reactome, and WIKIPATHWAY databases. Gene Set Enrichment Analysis (GSEA) was also performed using the ‘ClusterProfiler’ package, with all results visualized using gseaplot2.</p>
<p id="Par10">Predicted protein-protein interactions (PPI) were generated using the Genemania website (<a href="https://genemania.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://genemania.org/</a>), and interaction networks were reconstructed using Cytoscape.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Cell culture and drug treatment</h3>
<p id="Par11">The human leukemia T lymphocyte Jurkat (E6-1 clone, JE-6) cells, human OC cell line SKOV3, human OC cell line HEY, human renal epithelial cell line 293 T cells (HEK 293 T), and mouse ovarian epithelial carcinoma ID8 cells used in this study were all purchased from Procell Life Science &amp; Technology Co., Ltd. and Guangzhou Saiku Biotechnology Co., Ltd. JE-6 cells and SKOV3 cells were cultured in RPMI-1640 medium (KGL1503, KeyGEN) supplemented with 10% fetal bovine serum (FBS; FBS03, SinoBiological) and 1% penicillin-streptomycin (P/S; G4003, Servicebio). HEY cells, HEK 293 T cells, and ID8 cells were maintained in DMEM (high glucose; KGL1211, KeyGEN) containing 10% FBS and 1% P/S. All cell lines were cultured at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>.</p>
<p id="Par12">The small molecules used for cell treatment included: Daporinad (FK866, HY-50876, MCE), Nicotinamide (NAM, 4106, R&amp;D), NMN (HY-F0004, MCE), NR (HY-123033A, MCE), H-151 (1 μM; HY-112693, MCE), ionomycin (500 ng/mL; HY-13434, MCE), PMA (20 ng/mL; V1171, Promega), Olaparib (HY-10162, MCE), RU.521 (10 μM; M9447, AbMole), MG-132 (10 μM; HY-13259, MCE), and Cycloheximide (CHX; 10 μg/mL; M4879, AbMole). FK866, H-151, Olaparib, PMA, RU.521, MG-132, and CHX were dissolved and diluted in DMSO (D8371, Solarbio). NAM, NMN, and NR were prepared in sterile water, while ionomycin was dissolved and diluted in absolute ethanol. JE-6 T cell activation was achieved by adding ionomycin and PMA 4–6 h prior to cell collection.</p>
<p id="Par13">For the preparation of T cell supernatant used to treat OC cells or humanized OC organoids, to avoid direct effects of small molecule drugs on OC cells and organoids, the culture medium was replaced with fresh medium 24 h after small molecule treatment of T cells, followed by supernatant collection for subsequent treatment of OC cells or organoids.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Extraction and culture of patient-derived ovarian cancer organoids (PDOCO)</h3>
<p id="Par14">In this study, the human biological samples involved were approved by the hospital ethics committee. All samples were handled and processed according to the committee’s standards. Detailed information on the clinical OC samples can be found in Table S<a href="#MOESM8" class="usa-link">1</a>. OC tissues obtained from clinical sources must be processed within 24 h to ensure organoid viability. The OC tissue is washed and minced, then digested using AdDF12 containing DNAase (10 U/mL; DN25, Sigma), Y-27632 (5 μM; C629401, bioGenous), and Collagenase I (500 U/mL; C0130, Sigma). After digestion, the mixture is neutralized and filtered through a 100 μm cell strainer. Red blood cells are removed using red blood cell lysis buffer (B541001, Sangon), and the remaining cells are resuspended in an appropriate amount of BME matrix gel (3533-010-02, R&amp;D). The cell-matrix mixture is plated, and the plate is inverted and placed in a 37 °C, 5% CO<sub>2</sub> incubator for 30 minutes to allow the gel droplets to solidify. After solidification, PDOCO complete medium OCOM (ovarian cancer organoid medium, Table S<a href="#MOESM9" class="usa-link">2</a>, prepared according to the methods described in studies by Kopper O et al. and Maenhoudt N et al. [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]) is added, and the organoids are cultured in a 37 °C, 5% CO<sub>2</sub> incubator. The OCOM medium is replaced with fresh medium every 3 days.</p>
<p id="Par15">During PDOCO passaging, TrypLE (12604021, Gibco) is used for digestion. For cryopreservation of PDOCO, a self-prepared cryopreservation solution (AdDF12:FBS:DMSO = 1:8:1) is used. The samples are placed in a programmed freezing box and stored at –80°C, then transferred to liquid nitrogen for long-term storage.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Cell transfection</h3>
<p id="Par16">For NAMPT or SURF4 overexpression, the pLVX-Puro-Flag-NAMPT and pLenti-CMV-SURF4-HA-EF1-GFP-Puro lentiviral vector and empty vector were obtained from PPL (Public Protein/Plasmid Library). For SURF4 downregulation, pPLK/GFP-Puro-SURF4 shRNA (1#shRNA: GCTCTTTGCCATCAACGTATA, 2#shRNA: CCCATGCATGACTTCCTGAAA) and a vector containing a scrambled shRNA were purchased from PPL. With reference to a protocol described previously [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>], lentiviruses were generated by triple transfection of the above plasmids and helper plasmids into HEK 293 T cells and were then purified from the cell culture medium using PEG8000 solution.</p>
<p id="Par17">The virus solution was mixed with RPMI-1640 containing 10% FBS at a 3:2 ratio, and 7 × 10<sup>5 </sup>T cells were resuspended in the mixture. Polybrene (H8761, Solarbio) was added at a concentration of 10 μg/mL, and the cells were centrifuged at 37 °C, 1000 G for 2 h. The culture plate was then placed in a 37 °C, 5% CO<sub>2</sub> incubator. After 24 h, the culture medium was replaced with fresh RPMI-1640 containing 10% FBS and continued to be cultured. Starting from the third day after lentivirus infection, positive cells were screened with 1 μg/mL puromycin (ST551, Beyotime).</p></section><section id="Sec8"><h3 class="pmc_sec_title">Cell co-culture</h3>
<p id="Par18">Indirect Co-Culture: 1.5 mL of OC cells at a density of 1 × 10<sup>5</sup> cells/mL were plated in a 6-well plate. After HEY cells adhered, 1 mL of T cells at a density of 6 × 10<sup>5</sup> cells/mL was added to the co-culture insert. The co-culture was then placed in a 37 °C incubator, and NAD<sup>+</sup> content was detected after 24 h and 96 h of co-culture. A small amount of culture medium was supplemented on the second day.</p>
<p id="Par19">Direct Co-Culture: First, 4 × 10<sup>5</sup> OC cells were plated in a well plate. After adherence, a cell suspension containing 2 × 10<sup>6 </sup>T cells was slowly added. After 24 h of culture, the upper layer of T cells could be gently collected with a pipette, while the lower layer of OC cells was directly collected with RNA or protein lysis buffer.</p></section><section id="Sec9"><h3 class="pmc_sec_title">CCK-8 assay, colony formation, and chemotaxis assay</h3>
<p id="Par20">CCK-8 Assay: JE-6 cells were plated at a density of 3000 cells per well. SKOV3 and HEY cells were plated at a density of 1000 cells per well. During the assay, 10 μL of CCK-8 reagent (A311-02, Vazyme) was added to each well, followed by incubation at 37 °C in the dark for several hours. The OD values at 450 nm were measured at 0 h, 24 h, 48 h, 72 h, and 96 h.</p>
<p id="Par21">Colony Formation: OC cells were plated at a density of 1000 cells per well in 6-well plates. After adherence, a 1:1 mixture of T cell supernatant and fresh culture medium was added, and the medium was replaced every two days. On day 12, the cells were fixed, stained with crystal violet (G1014, Servicebio), and photographed against a white background.</p>
<p id="Par22">Chemotaxis Assay: T cells treated were resuspended at a density of 1 × 10<sup>6</sup>/mL in 100 μL fresh RPMI-1640 and added to the upper chamber of a 24-well co-culture plate. The lower chamber contained 500 μL of RPMI-1640 culture medium with 10% FBS. After 24 h of culture, the cells in the lower chamber were counted.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Cell cycle and apoptosis assays</h3>
<p id="Par23">Cell cycle analysis was performed using the Cell Cycle and Apoptosis Assay Kit (C1052, Beyotime). Apoptosis was detected using the Annexin V-FITC/PI Apoptosis Detection Kit (40302ES, Yeasen Bio). All procedures were carried out according to the manufacturer’s instructions. The cell cycle of each sample was statistically analyzed using MFLT32 software, and the apoptosis results were analyzed using FlowJo software.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Cytotoxicity assay</h3>
<p id="Par24">The treated JE-6 cells (E) were mixed with OC cells (T) Luciferase-GFP-SKOV3 or Luciferase-GFP-HEY at an effector-to-target ratio (E:T) of 9:1 and plated in opaque 96-well culture plates for co-culture for 24 h. The next day, 100 μL of ONE-Glo Luciferase Assay System reagent (E6110, Promega) was added to each well. After standing for 3 min to ensure complete cell lysis, the luminescence values were measured using a microplate reader.</p></section><section id="Sec12"><h3 class="pmc_sec_title">NAD<sup>+</sup>/NADH content detection</h3>
<p id="Par25">The NAD<sup>+</sup>/NADH content in cells was measured using the NAD<sup>+</sup>/NADH Detection Kit (WST-8 method) (S0175, Beyotime). All procedures were carried out according to the manufacturer’s instructions.</p></section><section id="Sec13"><h3 class="pmc_sec_title">RT-qPCR</h3>
<p id="Par26">Total RNA was extracted from tissues and cells using the RNA extraction solution (RK30129, Abclonal) and converted into cDNA using the ABScript Neo RT Master Mix (RK20433, Abclonal) according to the manufacturer’s instructions. RT-qPCR was performed using SYBR Green qPCR Master Mix (RK21219, Abclonal) with the reaction system and program according to the manufacturer’s instructions. RNA expression levels were normalized to β-actin, and ΔΔCT values were calculated for expression quantification. All primers were synthesized by Sangon Biotech (Table S<a href="#MOESM10" class="usa-link">3</a>).</p></section><section id="Sec14"><h3 class="pmc_sec_title">Western blot</h3>
<p id="Par27">Total protein samples were extracted from OC cell lines and tissues using protein lysis (P0013, Beyotime) supplemented with 1% protease/phosphatase inhibitors (P001, NCM). Proteins (20 μg/lane) were separated using 8–12% SDS-PAGE and then transferred onto a PVDF membrane (IPVH00010, Millipore). The membrane was then blocked in 5% nonfat milk and incubated overnight with specific primary antibodies at 4°C. The primary antibodies include: anti-NAMPT (1:1000; CSB-PA015422EA01HU, Cusabio), anti-CD8 (1:1000; <a href="https://www.ncbi.nlm.nih.gov/nuccore/T40010" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">T40010</a>, Abmart), anti-CD69 (1:1000; 10803-1-AP, Proteintech), anti-CD3D (1:1000; 16669-1-AP, Proteintech), anti-GZMB (1:1000; 16669-1-AP, Proteintech), anti-STING (1:5000; A21051, Abclonal), anti-pSTING (1:1000; AP1369, Abclonal), anti-IRF3 (1:1500; A19717, Abclonal), anti-pIRF3 (1:5000; AP1412, Abclonal), anti-SURF4 (1:1000; A16744, Abclonal), anti-Ubiquitin (1:1000; A19686, Abclonal), anti-DDDDK-Tag (1:20000; AE005, Abclonal), anti-HA (1:2000, AE008, Abclonal), anti-β-actin (1:10000; AC026, Abclonal), anti-HRP-conjugated GAPDH (1:10000; HRP-60004, Proteintech), and anti-α-tubulin (1:3000; GB11200, Servicebio). After incubation with the corresponding secondary antibodies, bands were detected using ECL chemiluminescence substrate (SQ203, Epizyme). The gray values of the Western blot were normalized to β-actin.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Immunoprecipitation</h3>
<p id="Par28">The total protein extraction method is the same as described in Section “Western Blot”. An appropriate amount of magnetic beads (RM02915, Abclonal) and corresponding antibodies are added according to the protein concentration. The mixture is then placed on a rotating mixer and incubated at 4 °C overnight for crosslinking. The next day, the complexes are washed three times with IP wash buffer (ddH<sub>2</sub>O contains 10% NP-40 (N8030, Solarbio), 5 M NaCl (A501218, Sangon), 1 M Tris-HCl (ST775, Beyotime), and 10% SDS (G2055, Servicebio)), and the complexes are resuspended in protein loading buffer. The antigens are eluted by heating at 100 °C for 10 min.</p></section><section id="Sec16"><h3 class="pmc_sec_title">ELISA assay</h3>
<p id="Par29">ELISA kits for GZMB (RK00089, Abclonal), IFNγ (RK00015, Abclonal), TNFα (RK00030, Abclonal) were used for detection. Supernatant samples were stored in an ultra-low temperature freezer, and all procedures were carried out according to the manufacturer’s instructions.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Immunofluorescence of cells and PDOCO</h3>
<p id="Par30">T cells were dropped onto gelatin-precoated glass slides and allowed to air-dry and adhere naturally. After adhesion, the cells were fixed and permeabilized. The slides were blocked with 3% BSA at room temperature for 1 h, followed by incubation with the primary antibody at 4 °C overnight. The next day, the slides were incubated with the corresponding fluorescent secondary antibody and DAPI (G1012, Servicebio). After incubation, an anti-fade mounting medium was applied, and the slides were sealed for confocal imaging.</p>
<p id="Par31">For PDOCO, staining was performed using the whole-mounting method. Under a stereomicroscope, organoids of appropriate size were selected. After fixation, permeabilization, and blocking, the organoids were incubated with the primary antibody at 4 °C overnight. The next day, the corresponding fluorescent secondary antibody was added for staining, followed by DAPI staining to label the nuclei.</p>
<p id="Par32">The primary antibodies include: anti-GOLGA2/GM130 antibody (1:500; 66662-1-Ig, Proteintech), anti-STING antibody (1:300), PAX8 (1:300; 10336-1-AP, Proteintech), CDH1 (1:300; 3195, CST), Ki67 (1:300; sc-23900, SANTA CRUZ), and PanCK (1:300; sc-8018, SANTA CRUZ). The dilution ratios of the fluorescent secondary antibodies used were as follows: anti-mouse Alexa Fluor 488® Conjugate (1:500; 4408, CST) and anti-rabbit Alexa Fluor 647® Conjugate (1:500; 4414, CST).</p></section><section id="Sec18"><h3 class="pmc_sec_title">Animal work</h3>
<p id="Par33">Five-week-old female C57BL/6 mice were obtained from Shanghai Jiesijie Laboratory Animal Co., LTD. All experimental mice were kept in SPF-grade animal facilities. 100 μL of a 1:1 mixture of DPBS and matrix gel (G4131, Servicebio), containing 1 × 10<sup>7</sup> ID8 cells, was injected subcutaneously into the axillary region of the mice. On the 7th day after transplanting ID8 cells, drug administration to the mice began. Both Olaparib and NAM were administered via intraperitoneal injection. The dosage of Olaparib was 50 mg/kg, and NAM was 500 mg/kg, with continuous injections for 20 days. Olaparib was diluted with DMSO and 20% SBE-β-CD (A600388, Sangon) for each use. NAM was first dissolved in PBS. All drugs were prepared immediately before use and kept on ice after preparation. Starting from the 7th day after tumor cell transplantation, the body weight of the mice and the size of the subcutaneously transplanted tumors were measured daily. The tumor size was calculated using the formula: Tumor volume (mm<sup>3</sup>) = (length × width<sup>2</sup>) / 2.</p></section><section id="Sec19"><h3 class="pmc_sec_title">H&amp;E staining and immunohistochemical staining</h3>
<p id="Par34">The fixed tissues were placed in a tissue cassette and processed in a gradient dehydration machine overnight for dehydration and paraffin embedding. The next day, the paraffin-embedded tissues were sectioned. H&amp;E staining of paraffin sections was carried out in the following steps: dewaxing and rehydration, staining, dehydration, and mounting.</p>
<p id="Par35">Immunohistochemical staining of paraffin sections was performed using the VECTASTAIN Immunohistochemistry Kit (PK-8501, Vector Laboratories) according to the steps of dewaxing and rehydration, antigen retrieval, blocking of endogenous peroxidase, blocking, primary antibody incubation, biotinylated secondary antibody incubation, HRP incubation, color development, counterstaining, dehydration, and mounting, all following the manufacturer’s instructions. The primary antibodies include: anti-CD69 (1:200) and anti-CD3D (1:200).</p></section><section id="Sec20"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par36">Values are represented as mean ± SD. GraphPad Prism 7 was used for unpaired Student’s t-test to compare two groups of means and generate p-values. We used standard designation of p-values throughout the figures (ns: not significant; *<em>p</em> &lt; 0.05; **<em>p</em> &lt; 0.01; ***<em>p</em> &lt; 0.001; ****<em>p</em> &lt; 0.0001).</p></section></section><section id="Sec21"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec22"><h3 class="pmc_sec_title">NAMPT-mediated NAD<sup>+</sup> biosynthesis regulates T cell function in OC microenvironment</h3>
<p id="Par37">In previous studies, we developed a TME scoring algorithm based on immune-related genes and defined OC patients with low TME scores as having a TME in a low immune-response state [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Further analysis and screening of factors influencing the TME of OC patients identified a link between NAD<sup>+</sup> metabolism and antitumor immunity (Fig. S<a href="#MOESM1" class="usa-link">1A</a>). In another prior study, we precisely classified OC patients into three immune subtypes, with each subtype predicting distinct antitumor immune responses [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. We subsequently analyzed the expression of NAD<sup>+</sup> anabolic-related genes across these immune subtypes and found that, compared to the C1 subtype (immune-activated), multiple genes involved in NAD<sup>+</sup> metabolism exhibited significantly reduced expression in the C3 subtype (immune-silent) (Fig. S<a href="#MOESM1" class="usa-link">1B</a>). These follow-up analyses based on previous findings suggest that NAD<sup>+</sup> metabolism may play a role in modulating the antitumor immune response within the TME of OC patients.</p>
<p id="Par38">The aforementioned findings were derived from whole-transcriptome data of OC tissues. To further investigate the regulatory relationship between NAD<sup>+</sup> metabolism and various cellular components within the OC microenvironment, with a specific focus on the differential NAD<sup>+</sup> biosynthesis between malignant OC cells and T cells, we conducted comprehensive analysis of single-cell RNA sequencing dataset <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217517" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE217517</a> (Fig. <a href="#Fig1" class="usa-link">1A</a>, Fig. S<a href="#MOESM1" class="usa-link">1C</a>). We found that non-malignant cells consistently exhibited lower expression of NAD<sup>+</sup> biosynthesis-related genes compared to their malignant counterparts, suggesting an elevated NAD<sup>+</sup> demand in OC cells (Fig. S<a href="#MOESM1" class="usa-link">1E</a>). In vitro indirect co-culture experiments demonstrated a significant decrease in NAD<sup>+</sup> levels in T cells over time, while OC cells maintained stable NAD<sup>+</sup> levels, indicating that cancer cells competitively deplete NAD<sup>+</sup> availability in microenvironmental T cells (Fig. <a href="#Fig1" class="usa-link">1C</a>).</p>
<p id="Par39">To more precisely explore the intrinsic relationship between NAD<sup>+</sup> metabolism and the anti-tumor effects of T cells, we performed cell type annotation on non-malignant cell populations. We found that, compared to malignant cells, the expression of NAMPT, the rate-limiting enzyme in the NAD<sup>+</sup> salvage synthesis pathway, was significantly reduced in T cells (Fig. S<a href="#MOESM1" class="usa-link">1F</a>). We further clustered the specific subtypes of T cells and identified five distinct T cell subtypes (Fig. <a href="#Fig1" class="usa-link">1D, E</a>). We observed that within CD8⁺ T cells, the expression of NAMPT showed an even stronger correlation with T cell anti-tumor functions, including cell activity, cytotoxic ability, and chemotactic capacity (Fig. <a href="#Fig1" class="usa-link">1F</a>, Fig. S<a href="#MOESM1" class="usa-link">1G</a>). These findings suggest that NAD⁺ anabolic metabolism plays a role in modulating T-cell anti-tumor responses, particularly in relation to the tumor-killing function of CD8<sup>+</sup> T cells. Moreover, NAMPT-mediated NAD<sup>+</sup> levels were found to positively regulate T cell anti-tumor function (Fig. <a href="#Fig1" class="usa-link">1G</a>, Fig. S<a href="#MOESM1" class="usa-link">1H</a>). In vitro experiments confirmed that NAMPT significantly increased intracellular NAD<sup>+</sup> levels in T cells, promoting both T cell proliferation and chemokine receptor expression (Fig. <a href="#Fig1" class="usa-link">1H–J</a>, Fig. S<a href="#MOESM1" class="usa-link">2A–C</a>). Furthermore, NAMPT-mediated elevation of NAD<sup>+</sup> levels enhanced the expression of the cytotoxic factors GZMB, as well as multiple cytotoxic cytokines including IFNγ and TNFα (Fig. <a href="#Fig1" class="usa-link">1K, L</a>). NAMPT was additionally found to enhance the expression of T cell infiltration- and activation-related proteins CD3D and CD69, which could be downregulated by the NAMPT inhibitor FK866 (Fig. <a href="#Fig1" class="usa-link">1M, N</a>, Fig. S<a href="#MOESM1" class="usa-link">2D</a>). These findings collectively demonstrate the crucial role of NAD<sup>+</sup> biosynthesis in T cell function, with particular emphasis on the NAMPT-mediated salvage pathway as a potent enhancer of T cell-mediated anti-tumor immunity.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Exogenous NAM supplementation enhances T cell proliferation, chemotaxis, and anti-tumor activity</h3>
<p id="Par40">Compared to genetic manipulation of T cells, exogenous supplementation with small molecules that boost NAD<sup>+</sup> levels offers greater convenience. In mammalian cells, the salvage pathway serves as the primary route for NAD<sup>+</sup> biosynthesis, utilizing three NAD<sup>+</sup> precursors: NAM (nicotinamide), NMN (nicotinamide mononucleotide), and NR (nicotinamide riboside). We initially evaluated the effects of these three NAD<sup>+</sup> precursors on OC cells to ensure that exogenous NAD<sup>+</sup> supplementation would not promote tumor progression. Our results indicated that neither NAM nor NR significantly stimulated OC cell growth (Fig. S<a href="#MOESM1" class="usa-link">2E</a>). Previous studies have reported that NAM exhibits superior cellular uptake efficiency compared to NR [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>], leading us to prioritize NAM as the NAD<sup>+</sup>-boosting small molecule for our investigation. Our study demonstrating that NAM effectively elevates NAD<sup>+</sup> levels and attenuates FK866-induced NAD<sup>+</sup> depletion (Fig. <a href="#Fig2" class="usa-link">2A</a>). Further experiments revealed that NAM supplementation reverses FK866-mediated suppression of T cell proliferation (Fig. <a href="#Fig2" class="usa-link">2B</a>, Fig. S<a href="#MOESM1" class="usa-link">2F, G</a>). NAM treatment alleviated G1 phase arrest in T cells, leading to increased cell populations in S and G2/M phases, suggesting that NAM-induced NAD<sup>+</sup> elevation promotes T cell proliferation through mechanisms analogous to NAMPT-mediated effects (Fig. <a href="#Fig2" class="usa-link">2C</a>, Fig. S<a href="#MOESM1" class="usa-link">2H, I</a>). Moreover, NAM-mediated NAD<sup>+</sup> restoration significantly reversed FK866-impaired chemotactic capacity and re-established the expression of chemokine receptors CCR4, CCR5, and CCR9 (Fig. <a href="#Fig2" class="usa-link">2D</a>, Fig. S<a href="#MOESM1" class="usa-link">2J</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Exogenous NAM supplementation enhances T cell-mediated anti-tumor responses.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373823_41419_2025_7939_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be32/12373823/d6c1b9b08052/41419_2025_7939_Fig2_HTML.jpg" loading="lazy" id="d33e798" height="755" width="693" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Exogenous supplementation of NAM in T cells significantly increases NAD<sup>+</sup> levels that were suppressed by FK866. <strong>B</strong> Decreased NAD<sup>+</sup> levels inhibit T cell proliferation, while NAM supplementation notably reverses this effect. <strong>C</strong>. NAM increases the number of T cells in the S/G2M phase. <strong>D</strong> Reduced NAD<sup>+</sup> levels impair T cell chemotaxis, whereas NAM enhances T cell chemotactic ability. <strong>E</strong>, <strong>F</strong> NAM promotes the expression of T cell infiltration and activation markers CD3D, CD69, and GZMB. <strong>G</strong> NAM supplementation upregulates the expression of T cell anti-tumor factors GZMB, IFNγ, and IL2. <strong>H</strong> Reduced NAD<sup>+</sup> levels in T cells inhibit their cytotoxic ability, while NAM enhances T cell-mediated killing. <strong>I</strong> NAM enhances T cell anti-tumor function, inhibiting the proliferation of SKOV3 cells. <strong>J</strong> NAM enhances T cell anti-tumor function, inhibiting the proliferation of HEY cells. <strong>K</strong>, <strong>L</strong> NAM enhances T cell-mediated killing of OC cells and promotes apoptosis of SKOV3. <strong>M</strong> Construction of PDOCOs and their validation by immunofluorescence staining for Ki67, CDH1, PanCK, and PAX8. <strong>N</strong> Treatment of PDOCOs with T cell supernatant. <strong>O</strong> Increased NAD<sup>+</sup> levels in T cells enhance their inhibitory effect on PDOCOs growth. <strong>P</strong>, <strong>Q</strong> NAM enhances the inhibitory effect of T cells on PDOCOs growth, with a significant decrease in Ki67 expression.</p></figcaption></figure><p id="Par41">The FK866-mediated NAD<sup>+</sup> depletion significantly reduced the expression levels of CD3D, CD69, and GZMB in T cells, while NAM supplementation effectively reversed this suppression of T cell activation (Fig. <a href="#Fig2" class="usa-link">2E, F</a>, Fig. S<a href="#MOESM1" class="usa-link">3A, B</a>). The expression of T cell activation receptor IL2R, along with various anti-tumor secretory factors (GZMB, IFNγ) and the inflammatory cytokine IL2, showed strong correlation with intracellular NAD<sup>+</sup> levels (Fig. <a href="#Fig2" class="usa-link">2G</a>, Fig. S<a href="#MOESM1" class="usa-link">3C, D</a>). To further investigate the impact of elevated NAD⁺ levels in T cells on their tumor-killing efficacy, we conducted luciferase-based cytotoxicity assays. The results demonstrated that inhibition of NAD<sup>+</sup> biosynthesis in T cells attenuated their tumoricidal activity, whereas NAM supplementation significantly enhances the cytotoxic capacity of T cells against OC cells (Fig. <a href="#Fig2" class="usa-link">2H</a>, Fig. S<a href="#MOESM1" class="usa-link">3E–G</a>). Furthermore, NAM-mediated NAD<sup>+</sup> elevation substantially augmented the secretion of anti-tumor factors from T cells, leading to significant inhibition of proliferation and increased apoptosis in co-cultured OC cells (Fig. <a href="#Fig2" class="usa-link">2I–L</a>, Fig. S<a href="#MOESM1" class="usa-link">3H–J</a>). Patient-derived organoid, as an emerging model system, retain genetic lineages and pathological characteristics similar to their parental tumors, thereby accurately recapitulating the complexity, microarchitecture, and growth patterns of tumors in vivo. Here, we established PDOCO models (Fig. <a href="#Fig2" class="usa-link">2M</a>). Consistent with the cell line models, we co-cultured PDOCOs with NAM-treated T cells and observed significantly reduced Ki67 intensity, demonstrating that NAM enhances the inhibitory effect of T cells on tumor proliferation (Fig. <a href="#Fig2" class="usa-link">2N–Q</a>). Moreover, T cell exhaustion represents a critical factor contributing to poor anti-tumor functionality despite T cell infiltration, and alleviating this exhausted state is key to reversing “cold” immune microenvironments. Our findings also demonstrate that NAM can ameliorate NAD<sup>+</sup> deficiency-induced T cell exhaustion phenotypes (Fig. S<a href="#MOESM1" class="usa-link">3K–M</a>). These results collectively underscore the crucial role of NAD<sup>+</sup> levels in maintaining T cell anti-tumor functionality and establish NAM as an effective NAD<sup>+</sup> precursor for enhancing T cell-mediated anti-tumor responses.</p></section><section id="Sec24"><h3 class="pmc_sec_title">The p-STING/p-IRF3 axis plays a crucial role in NAD<sup>+</sup>-mediated activation of T cell function and anti-tumor immunity</h3>
<p id="Par42">Targeting the STING signaling pathway has emerged as a promising strategy for enhancing anti-tumor immunity. While recent studies have gradually elucidated the functional significance of STING signaling in T cells, the role of endogenous STING pathway activation in T cell responses remains largely unexplored. In this study, we demonstrate that both NAMPT-mediated and NAM-induced elevation of intracellular NAD<sup>+</sup> levels effectively activate the p-STING/p-IRF3 signaling axis (Fig. <a href="#Fig3" class="usa-link">3A–D</a>, Fig. S<a href="#MOESM1" class="usa-link">4A, B</a>).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. The p-STING/p-IRF3 axis plays a crucial role in NAD<sup>+</sup>-mediated activation of T cell function and anti-tumor immunity.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373823_41419_2025_7939_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be32/12373823/475cd8dfc676/41419_2025_7939_Fig3_HTML.jpg" loading="lazy" id="d33e927" height="634" width="790" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>, <strong>B</strong> NAMPT promotes the activation of the p-STING/p-IRF3 axis in T cells. <strong>C-D</strong>. Reduced NAD<sup>+</sup> levels inhibit the activation of the p-STING axis, while NAM promotes the activation of the p-STING/p-IRF3 axis in T cells. <strong>E</strong>, <strong>F</strong> Inhibition of STING significantly attenuates the NAM-promoted activation of downstream p-IRF3. <strong>G</strong>, <strong>H</strong> Inhibition of STING in T cells markedly reduces the expression of NAM-activated anti-tumor effector proteins. <strong>I</strong> Inhibition of STING in T cells significantly downregulates the expression of NAM-activated anti-tumor factors. <strong>J</strong><strong>–L</strong> Inhibition of STING in T cells significantly weakens the NAM-enhanced cytotoxic ability of T cells. <strong>J</strong> After STING inhibition in T cells, the NAM-promoted inhibitory effect of T cells on the proliferation of HEY is significantly reduced. <strong>K</strong>, <strong>L</strong> After STING inhibition in T cells, the number of apoptotic SKOV3 decreases. <strong>M</strong> STING inhibition diminishes the NAM-promoted enhancement of T cell chemotaxis. <strong>N</strong>, <strong>O</strong> STING inhibition weakens the NAM-promoted proliferation of T cells, reducing the number of cells in the S/G2M phase.</p></figcaption></figure><p id="Par43">To clarify that the NAD<sup>+</sup> level-mediated activation of the p-STING axis directly acts on STING, we further investigated the inhibitory effects of the cGAS inhibitor RU.521 and the STING inhibitor H-151 on NAM-mediated p-STING axis activation. The results showed that H-151 significantly inhibited NAM-activated p-STING, while RU.521 had a weaker inhibitory effect on the STING axis activation induced by NAM. (Fig. <a href="#Fig3" class="usa-link">3E, F</a>, Fig. S<a href="#MOESM1" class="usa-link">4C</a>). Furthermore, H-151 not only inhibited the p-STING/p-IRF3 axis but also significantly reduced the expression of T cell infiltration and activation markers (CD3D and CD69) as well as anti-tumor factors (GZMB, IFNγ, and TNFα) (Fig. <a href="#Fig3" class="usa-link">3G–I</a>, Fig. S<a href="#MOESM1" class="usa-link">4D</a>).</p>
<p id="Par44">Moreover, inhibition of the STING axis significantly suppressed the NAM-mediated enhancement of T cell cytotoxic activity, as evidenced by a reduction in the inhibitory effect on OC cell proliferation and a decrease in OC cell apoptosis (Fig. <a href="#Fig3" class="usa-link">3J–L</a>, Fig. S<a href="#MOESM1" class="usa-link">4E</a>). H-151 not only diminished NAMPT-promoted T cell proliferation (Fig. S<a href="#MOESM1" class="usa-link">2A</a>) but also inhibited NAM-induced enhancement of T cell proliferation and chemotactic capacity (Fig. <a href="#Fig3" class="usa-link">3M–O</a>, Fig. S<a href="#MOESM1" class="usa-link">4F–J</a>). These findings collectively indicate that NAD<sup>+</sup>-mediated augmentation of T cell proliferation, chemotaxis, and anti-tumor cytotoxicity is dependent on the activation of the endogenous STING signaling axis.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Elevated NAD<sup>+</sup> levels downregulate SURF4 to promote p-STING axis activation</h3>
<p id="Par45">Following cellular stimulation by external factors such as tumor-derived DNA, intracellular cGAS protein becomes activated, triggering the translocation of STING protein from the endoplasmic reticulum (ER) to the Golgi apparatus, where it undergoes phosphorylation and subsequently activates downstream p-TBK and p-IRF3, ultimately leading to interferon signaling transcription [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Throughout this process, STING undergoes ER-Golgi trafficking and completes its functional activation at the Golgi apparatus [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. We discovered that NAMPT-mediated NAD<sup>+</sup> levels significantly influence ER-Golgi transport, particularly protein trafficking from the ER to the Golgi (Fig. <a href="#Fig4" class="usa-link">4A</a>). Consequently, we examined the intracellular localization of STING protein in T cells and found that NAMPT overexpression resulted in increased STING accumulation at the Golgi apparatus compared to controls (Fig. <a href="#Fig4" class="usa-link">4B</a>). Conversely, FK866-mediated NAD<sup>+</sup> depletion reduced STING localization at the Golgi, while NAM supplementation restored STING accumulation at the Golgi (Fig. <a href="#Fig4" class="usa-link">4C</a>). These findings suggest that intracellular NAD<sup>+</sup> levels influence STING retention at the Golgi apparatus, indicating that NAD<sup>+</sup> level alterations may affect STING intracellular trafficking.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. Elevated NAD<sup>+</sup> levels promote ubiquitination-mediated degradation of SURF4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373823_41419_2025_7939_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be32/12373823/3e0d2651a709/41419_2025_7939_Fig4_HTML.jpg" loading="lazy" id="d33e1077" height="1000" width="717" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> The NAD<sup>+</sup> level in T cells regulates protein transport between the ER and the Golgi apparatus. <strong>B</strong> Overexpression of NAMPT promotes the aggregation of STING on the Golgi apparatus in T cells. <strong>C</strong> Reduced NAD<sup>+</sup> levels decrease the aggregation of STING on the Golgi apparatus in T cells, while NAM promotes the re-aggregation of STING on the Golgi apparatus. <strong>D</strong> Identification of key molecules related to ER-Golgi transport and NAD<sup>+</sup> metabolism. <strong>E</strong> Identifying SURF4 as a key protein via PPI analysis. <strong>F</strong>, <strong>G</strong> Overexpression of NAMPT downregulates SURF4 in T cells. <strong>H</strong>, <strong>I</strong> Reduced NAD<sup>+</sup> levels increase SURF4 expression, while NAM supplementation downregulates SURF4. <strong>J</strong> Downregulation of SURF4 promotes the expression of infiltration and activation marker genes. <strong>K</strong> Knockdown of SURF4 activates the p-STING/p-IRF3 axis in T cells and upregulates the expression of anti-tumor proteins. <strong>L</strong>. Overexpression of SURF4 inhibits the activation of the p-STING/p-IRF3 axis and downregulates the expression of infiltration and activation proteins, while NAM reverses these effects by downregulating SURF4. <strong>M</strong>, <strong>N</strong> The degradation rate of SURF4 protein slows down when NAD<sup>+</sup> levels are reduced, while NAM accelerates SURF4 protein degradation. <strong>O</strong>, <strong>P</strong> NAM promotes the ubiquitination-dependent degradation of SURF4 protein. <strong>Q</strong> NAM supplementation increases the abundance of ubiquitinated SURF4 protein in T cells. <strong>R</strong> Overexpression of NAMPT, mediated by changes in NAD<sup>+</sup> levels, increases the abundance of ubiquitinated SURF4 protein in HEK293T cells.</p></figcaption></figure><p id="Par46">Intracellular protein transport relies on vesicles, and due to the unique structure of STING, it cannot directly bind to vesicles and requires intermediary mediators [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. To identify proteins influencing STING Golgi retention, we screened NAMPT-associated differentially expressed genes and GSEA-enriched ER-Golgi pathway genes, ultimately identifying 14 potential candidates (Fig. <a href="#Fig4" class="usa-link">4D</a>). Protein-protein interaction prediction analysis revealed that SURF4 not only potentially interacts with STING but is also indirectly regulated by NAMPT, suggesting its potential role in NAD<sup>+</sup>-mediated p-STING axis activation (Fig. <a href="#Fig4" class="usa-link">4E</a>). In NAMPT-overexpressing T cells, SURF4 protein levels were downregulated (Fig. <a href="#Fig4" class="usa-link">4F, G</a>). Conversely, FK866-mediated NAD<sup>+</sup> depletion increased intracellular SURF4 expression, which was reversed by NAM supplementation (Fig. <a href="#Fig4" class="usa-link">4H, I</a>). These results demonstrate that SURF4 protein expression is significantly influenced by NAD<sup>+</sup> levels.</p>
<p id="Par47">Recent studies have reported that SURF4 recruits STING, facilitating its retrograde transport from the Golgi to the ER, while SURF4 knockdown results in STING accumulation at the Golgi [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. In certain contexts, SURF4-mediated signal termination may prevent excessive immune activation [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Protein docking analysis revealed that the docking model between STING and SURF4 suggests a highly efficient binding interaction (Fig. S<a href="#MOESM1" class="usa-link">5A</a>, Table S<a href="#MOESM11" class="usa-link">4</a>). Furthermore, we detected a specific binding between STING and SURF4 proteins in both JE-6 T cells and HEK 293 T cells (Fig. S<a href="#MOESM1" class="usa-link">5B, C</a>). SURF4 knockdown in T cells resulted in elevated CD3D, CD69, and GZMB expression, along with significant activation of the p-STING/p-IRF3 axis (Fig. <a href="#Fig4" class="usa-link">4J, K</a>, Fig. S<a href="#MOESM1" class="usa-link">5D</a>). Conversely, SURF4 overexpression in T cells significantly reduced the expression of activation markers (CD3D, CD69) and anti-tumor proteins (GZMB), while simultaneously suppressing the p-STING/p-IRF3 axis (Fig. <a href="#Fig4" class="usa-link">4L</a>). However, NAM supplementation reversed SURF4-mediated suppression of activation markers and reactivated the p-STING/p-IRF3 axis (Fig. <a href="#Fig4" class="usa-link">4L</a>). These collective findings demonstrate that SURF4 participates in NAD<sup>+</sup>-mediated regulation of the p-STING/p-IRF3 axis and downstream T cell activation. Elevated NAD<sup>+</sup> levels suppress SURF4 expression, promoting STING stabilization at the Golgi apparatus and thereby enhancing p-STING/p-IRF3 axis-mediated T cell activation.</p></section><section id="Sec26"><h3 class="pmc_sec_title">Elevated NAD<sup>+</sup> levels promote ubiquitination-mediated degradation of SURF4</h3>
<p id="Par48">To investigate the regulatory mechanism of NAD<sup>+</sup> on SURF4 expression, we examined SURF4 transcriptional levels under different NAD<sup>+</sup> conditions. Our results demonstrated that NAD<sup>+</sup> levels did not affect SURF4 transcription (Fig. S<a href="#MOESM1" class="usa-link">5E, F</a>). Through protein synthesis inhibition experiments, we observed that reduced NAD<sup>+</sup> levels significantly slowed SURF4 protein degradation in T cells, while NAM-mediated NAD<sup>+</sup> elevation accelerated SURF4 degradation, suggesting that NAD<sup>+</sup> levels regulate SURF4 expression through post-translational modification of protein stability (Fig. <a href="#Fig4" class="usa-link">4M, N</a>).</p>
<p id="Par49">The protein modification database suggests that SURF4 protein can undergo various post-translational modifications, with ubiquitination being one that has been predicted and reported in multiple studies (Fig. S<a href="#MOESM1" class="usa-link">5G</a>). We therefore focused on NAD<sup>+</sup>-mediated ubiquitination of SURF4. Proteasome inhibitor MG-132 treatment significantly attenuated NAM-induced SURF4 degradation, supporting the involvement of ubiquitin-proteasome system (Fig. <a href="#Fig4" class="usa-link">4O, P</a>). Further examination of SURF4 ubiquitination under different NAD<sup>+</sup> conditions revealed that NAD<sup>+</sup> depletion significantly reduced SURF4 ubiquitination in T cells, while NAM supplementation increased ubiquitination levels (Fig. <a href="#Fig4" class="usa-link">4Q</a>). Similarly, in HEK 293 T cells, NAMPT overexpression enhanced SURF4 ubiquitination (Fig. <a href="#Fig4" class="usa-link">4R</a>). To further investigate the regulatory factors involved in NAM-mediated SURF4 ubiquitination in T cells, we analyzed the interactions among NAMPT, SURF4, E3 ubiquitin ligases, and deubiquitinating enzymes (DUBs). Our analysis revealed correlations between the expression of NAMPT/SURF4 and both the E3 ubiquitin ligase PELI1 and the deubiquitinase USP47 (Fig. S<a href="#MOESM1" class="usa-link">5H, I</a>). External dataset <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53772" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE53772</a> demonstrated that FK866 treatment upregulates USP47 expression, while in vitro experiments confirmed that NAM supplementation suppresses USP47 expression (Fig. S<a href="#MOESM1" class="usa-link">5J, K</a>). Single-cell RNA sequencing analysis of OC showed an inverse correlation between USP47 expression and various antitumor factors within T cell populations (Fig. S<a href="#MOESM1" class="usa-link">5L</a>).</p>
<p id="Par50">These findings collectively demonstrate that both NAMPT- and NAM-mediated NAD<sup>+</sup> elevation promotes ubiquitination-mediated degradation of SURF4 protein, potentially through regulation of USP47. This downregulation of SURF4 enables STING protein retention at the Golgi apparatus, subsequently activating the downstream p-IRF3 axis and interferon signaling, ultimately enhancing T cell-mediated anti-tumor immunity.</p></section><section id="Sec27"><h3 class="pmc_sec_title">Enhancing T cell NAD<sup>+</sup> levels potentiates anti-tumor immunity during PARPi treatment in OC</h3>
<p id="Par51">The activation of STING in immune cells primarily occurs through the acquisition of exogenous tumor DNA or tumor-derived cGAMP [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. PARP inhibitors (PARPi) induce DNA damage by preventing the repair of single-strand breaks, resulting in the accumulation of double-stranded DNA (dsDNA) that not only activates the cGAS-cGAMP pathway but is also released into the TME upon cell death [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. The immunomodulatory effects mediated by PARPi-induced dsDNA generation contribute to their therapeutic efficacy independent of BRCA mutation status, with their effectiveness requiring intact T cell-mediated immune responses [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Therefore, we investigated the potential of enhancing T cell NAD<sup>+</sup> levels to augment anti-tumor immunity during PARPi treatment at both cellular and animal levels.</p>
<p id="Par52">Our findings revealed that Olaparib alone did not directly activate the p-STING/p-IRF3 axis or downstream anti-tumor activity in T cells (Fig. S<a href="#MOESM1" class="usa-link">6A</a>). However, supernatant from Olaparib-treated OC cells significantly activated the p-STING/p-IRF3 axis in T cells, accompanied by upregulation of infiltration marker CD3D, activation marker CD69, and cytotoxic factor GZMB (Fig. <a href="#Fig5" class="usa-link">5A, B</a>, Fig. S<a href="#MOESM1" class="usa-link">6B, D</a>). These results indicate that Olaparib requires OC cell mediation to activate T cell anti-tumor function in the TME. Furthermore, the enhancement of T cell anti-tumor activity mediated by Olaparib-treated OC cells was dependent on intracellular NAD<sup>+</sup> levels, as NAD<sup>+</sup> depletion in T cells significantly inhibited this activation (Fig. <a href="#Fig5" class="usa-link">5A, B</a>, Fig. S<a href="#MOESM1" class="usa-link">6C, D</a>). Direct co-culture experiments of T cells with OC cells demonstrated that Olaparib-treated cancer cells only promoted T cell anti-tumor function when T cells maintained high NAD<sup>+</sup> levels (Fig. <a href="#Fig5" class="usa-link">5C, D</a>). Intracellular localization analysis revealed that STING localization in T cells was highly sensitive to NAD<sup>+</sup> level fluctuations when mediated by Olaparib-treated OC cells, emphasizing the importance of Golgi-localized STING for downstream p-STING/p-IRF3 axis activation and enhanced anti-tumor function following exogenous stimulation (Fig. S<a href="#MOESM1" class="usa-link">6E</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. Enhancing T cell NAD<sup>+</sup> levels potentiates anti-tumor immunity during PARPi treatment in OC.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373823_41419_2025_7939_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be32/12373823/91b090e0231d/41419_2025_7939_Fig5_HTML.jpg" loading="lazy" id="d33e1315" height="999" width="722" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> The supernatant of OC cells treated with Olaparib can activate the expression of anti-tumor-related proteins in T cells. Low NAD<sup>+</sup> levels in T cells weaken the Olaparib-OC cell-mediated activation of T cells, which can be reversed by NAM supplementation. <strong>B</strong> Olaparib-treated OC cells activate IFNγ secretion in T cells, and the secretion level is regulated by the basal NAD<sup>+</sup> content in T cells. Sufficient NAD<sup>+</sup> levels promote IFNγ secretion in stimulated T cells. <strong>C</strong>, <strong>D</strong> Direct co-culture of OC cells and T cells further confirms that the anti-tumor activity of T cells mediated by Olaparib-treated OC cells is influenced by NAD<sup>+</sup> levels. Low NAD<sup>+</sup> levels inhibit T cell activation, while NAM supplementation enhances the anti-tumor function of T cells. <strong>E</strong> Schematic diagram of the combined treatment regimen of Olaparib and NAM in a subcutaneous tumor mouse model. <strong>F</strong> No significant changes in body weight were observed in any treatment group during the treatment period. <strong>G</strong>, <strong>H</strong> The subcutaneous tumors in the Olaparib-NAM combination treatment group showed significant shrinkage, with effects significantly superior to those of the Olaparib monotherapy or NAM monotherapy groups (<em>n</em> = 5 per group). <strong>I</strong> The expression levels of T cell anti-tumor-related genes (Cd8a, Cd3d, Cd69, Gzmb, Ifnγ, and Tnf) were significantly upregulated in the subcutaneous tumors of the Olaparib-NAM combination treatment group. <strong>J</strong> The expression of the T cell exhaustion marker gene Pdcd1 was significantly reduced in the subcutaneous tumors of the Olaparib-NAM combination treatment group. <strong>K</strong>, <strong>L</strong> Immunohistochemistry showed significantly increased expression of CD3D and CD69 in the subcutaneous tumors of the Olaparib-NAM combination treatment group. <strong>M</strong> Schematic diagram summarizing the research model of this study.</p></figcaption></figure><p id="Par53">We found pre-treatment of T cells with NAM, combined with Olaparib, significantly inhibited PDOCO growth and induced cell death, as evidenced by markedly reduced Ki67 expression, demonstrating the efficacy of NAM in potentiating Olaparib-induced T cell activation (Fig. S<a href="#MOESM1" class="usa-link">6F, G</a>). In vivo studies showed that while neither Olaparib nor NAM alone significantly reduced subcutaneous tumor growth in mice, their combination resulted in substantial tumor regression, suggesting NAM as a potential adjuvant to enhance PARPi efficacy (Fig. <a href="#Fig5" class="usa-link">5E–H</a>). Tumors from the combination treatment group exhibited significantly increased expression of Cd8a, Cd3d, Cd69, Gzmb, Ifnγ, and Tnf, along with downregulation of the immune checkpoint gene Pdcd1 (Fig. <a href="#Fig5" class="usa-link">5I–L</a>). These results highlight the potential of NAM as an adjuvant to enhance T cell-mediated anti-tumor immunity during PARPi treatment in OC.</p></section></section><section id="Sec28"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par54">The complexity of the OC microenvironment significantly impacts patient outcomes. A comprehensive analysis of this microenvironment facilitates understanding of inter-component interactions and identification of regulatory factors affecting anti-tumor immunity, thereby enabling development of novel therapeutic strategies [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Our previous research characterized the anti-tumor immune status in OC microenvironment, revealing that most patients exhibit an immune-silent microenvironment [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. This immunosuppressive state not only limits anti-tumor immune cell function but also reduces immunotherapy efficacy, accelerates chemotherapy resistance, and promotes tumor progression [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p>
<p id="Par55">Our earlier findings suggested NAD<sup>+</sup> metabolism might regulate the immune-silent state in OC microenvironment [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. As a fundamental biological element, NAD<sup>+</sup> plays crucial roles in energy metabolism, oxidative stress, and aging [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Previous studies have demonstrated that tumor cells exhibit higher NAD<sup>+</sup> demands compared to non-tumor cells, a phenomenon dependent on the Warburg effect, where tumor cells must increase NAD<sup>+</sup> levels to support high glycolytic activity [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. However, this tumor-specific metabolic alteration may compromise NAD<sup>+</sup> availability for other immune components in the microenvironment [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Through co-culture experiments, we confirmed that OC cells restrict NAD<sup>+</sup> availability for T cells, while T cell NAD<sup>+</sup> levels are closely associated with their anti-tumor functionality. T cell activation depends on NAD<sup>+</sup> for energy production and signal transduction, and NAD<sup>+</sup> depletion may lead to T cell exhaustion, characterized by reduced proliferation, cytokine production, and cytotoxic activity. Previous research has shown that NAD<sup>+</sup> supplementation significantly enhances CAR-T cell anti-tumor activity in vitro and prolongs survival in animal models of CAR-T therapy and immune checkpoint blockade, suggesting NAD<sup>+</sup> may improve T cell-based immunotherapy efficacy [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>–<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. In this study, we found that elevating T cell NAD<sup>+</sup> levels promotes proliferation, upregulates chemokine receptor expression, and enhances chemotactic capacity. Furthermore, increased NAD<sup>+</sup> levels promote expression of T cell infiltration and activation markers, stimulate anti-tumor factor secretion, and enhance tumor cell killing. NAM, as an NAD<sup>+</sup> precursor, effectively enhances T cell anti-tumor function. Although NAM conversion to NAD<sup>+</sup> depends on NAMPT activity, studies have shown that NAM can reverse FK866-induced cytotoxicity [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Our research demonstrated that NAM restores FK866-suppressed NAD<sup>+</sup> levels and reverses FK866-inhibited T cell anti-tumor activity. Importantly, exogenous NAM supplementation does not promote OC progression [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. These findings suggest that targeting NAD<sup>+</sup> metabolism represents a promising therapeutic strategy, potentially reprogramming the TME metabolic landscape and restoring immune cell function through promoting NAD<sup>+</sup> biosynthesis, reducing NAD<sup>+</sup> consumption, or supplementing NAD<sup>+</sup> precursors, ultimately improving OC patient outcomes.</p>
<p id="Par56">The cGAS-STING axis serves as a crucial regulator of cancer immunity, with its mediated immune-supportive microenvironment potentially inhibiting malignant progression [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. Although STING is generally believed to function by bridging innate and adaptive immunity upon activation, increasing evidence suggests that adaptive immune cells can directly respond to STING engagement, with STING activation in adaptive immune cells producing higher IFN levels than in innate immune cells [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Previous studies have indicated that intracellular STING signaling promotes stem-like CD8<sup>+</sup> T cell maintenance, suggesting T cell STING activation enhances anti-tumor immune responses [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. We found that elevating T cell NAD<sup>+</sup> levels activates the STING axis and downstream p-IRF3 signaling, thereby enhancing T cell anti-tumor function. Previous research on NAD<sup>+</sup> regulation of STING signaling has primarily focused on cellular senescence. Contrary to our findings, studies by Hou et al. and Myakala K et al. demonstrated that reduced NAD<sup>+</sup> levels mediate STING axis activation, inducing pro-inflammatory factor expression and cellular senescence, while NR supplementation alleviates this pro-inflammatory microenvironment and slows Alzheimer’s disease progression [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>, <a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. However, other studies have shown that NAD<sup>+</sup> can induce pro-inflammatory microenvironments, promoting macrophage M2-to-M1 polarization or tumor growth [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. These discrepancies may result from differences in disease models.</p>
<p id="Par57">STING axis-mediated interferon signaling activation depends on STING protein conformational changes following cGAMP binding, subsequent STING translocation from ER to Golgi, and downstream IRF3 signaling activation at the Golgi, leading to IRF3 phosphorylation and nuclear translocation for interferon pathway activation [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. We found that NAD<sup>+</sup> levels regulate intracellular protein transport, particularly ER-Golgi trafficking. Deng et al. reported that impaired STING transport between ER and Golgi leads to sustained autoimmune activation, suggesting Golgi localization is crucial for STING downstream signaling activation [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Through co-localization experiments, we demonstrated that increased NAD<sup>+</sup> levels promote STING stabilization at the Golgi, potentially representing a key mechanism for NAD<sup>+</sup>-enhanced T cell anti-tumor immunity. By screening NAD<sup>+</sup>-regulated genes involved in ER-Golgi protein transport, we identified SURF4 as a key player in this process. Previous studies have demonstrated SURF4’s robust protein transport capabilities, particularly in mediating Golgi-to-ER retrograde transport. Mukai K et al. first proposed in 2021 that SURF4 mediates STING retrograde transport to ER, affecting STING Golgi localization [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. We confirmed SURF4-STING interaction in T cells and demonstrated that SURF4 downregulation activates T cell STING axis and downstream anti-tumor immunity. Furthermore, T cell SURF4 expression is regulated by NAD<sup>+</sup> levels, with increased NAD<sup>+</sup> downregulating SURF4. Thus, NAD<sup>+</sup> regulation of STING axis activation in T cells is mediated by SURF4. Previous studies have shown that NAD<sup>+</sup> levels can affect post-translational modifications such as acetylation and PARylation by regulating catabolic enzymes PARPs and SIRTs [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Mass spectrometry studies have predicted SURF4 ubiquitination [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. In this study, we confirmed NAD<sup>+</sup>-mediated SURF4 ubiquitination through IP experiments. Collectively, increased T cell NAD<sup>+</sup> levels promote SURF4 ubiquitination and degradation, reducing STING binding and retrograde transport, thereby stabilizing STING at the Golgi and enhancing T cell interferon signaling activation.</p>
<p id="Par58">Immune cell STING activation depends on acquisition of exogenous tumor DNA or tumor-derived cGAMP [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Recent studies have shown that PARPi-induced dsDNA generation mediates immune response regulation, contributing to BRCA mutation-independent therapeutic effects, with efficacy requiring intact T cell-mediated immune responses [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. We found that PARPi Olaparib does not directly activate T cells but can activate T cells through OC cell mediation, regulated by T cell NAD<sup>+</sup> levels. NAM-Olaparib combination therapy significantly enhanced OC growth inhibition and increased intratumoral T cell activation in mouse models. These results suggest that NAM as an adjuvant can enhance Olaparib efficacy by increasing T cell NAD<sup>+</sup> levels, further activating the STING axis, thereby enhancing T cell anti-tumor function, providing a novel strategy for OC treatment.</p>
<p id="Par59">However, the clinical application of NAM still presents several challenges. A study demonstrated that after a single 200 mg oral dose of NAM, the plasma concentration peaked at 0.5 h and subsequently declined, while NAD<sup>+</sup> levels reached maximum concentration at 12 hours [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Furthermore, high-dose NAM (3–6 g) administration significantly elevated NAD<sup>+</sup> levels but also induced adverse effects including nausea and vomiting [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. These pharmacokinetic characteristics indicate that NAM dosing regimens require careful optimization to maintain effective drug concentrations while minimizing side effects. Although NAM-PARPi combination enhances anti-tumor efficacy, their overlapping toxicity profiles may contribute to hematologic adverse events. The combination could exacerbate leukopenia and thrombocytopenia, potentially increasing risks of infection and bleeding [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. Additionally, while NAM activates the STING pathway to enhance immune responses, its combination with PARPi may disrupt immune cell balance in the tumor microenvironment by promoting regulatory T cell (Treg) proliferation, thereby potentially compromising anti-tumor immunity [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. Consequently, future studies should focus on optimizing NAM dosing regimens and investigating individual variations in response to NAM-PARPi combinations to improve both efficacy and safety in ovarian cancer treatment.</p>
<p id="Par60">This study has several limitations that need to be addressed. In the mechanistic investigation, the regulation of SURF4 ubiquitination mediated by NAM-induced NAD<sup>+</sup> elevation requires further clarification in subsequent studies. Through bioinformatics analysis, we identified the deubiquitinase USP47 as being associated with NAD<sup>+</sup> levels and correlated with various anti-tumor genes in ovarian cancer microenvironment T cells. Therefore, future research will focus on elucidating the detailed mechanisms by which NAD<sup>+</sup> levels regulate SURF4 ubiquitination. Additionally, while protein docking has predicted multiple potential interaction sites between SURF4 and STING, the specific binding sites between these two proteins need to be experimentally validated in follow-up studies. Finally, the preclinical animal experiments combining NAM with PARPi require further refinement, and the immunostimulatory effects of NAM need to be evaluated through additional experiments.</p>
<p id="Par61">In conclusion, this study reveals the crucial role of NAD<sup>+</sup> metabolism in regulating T cell function, with NAD<sup>+</sup> increase promoting SURF4 ubiquitination and degradation, thereby stabilizing STING at the Golgi and enhancing T cell anti-tumor effects. Furthermore, this study provides theoretical basis for NAM as an adjuvant to enhance PARPi efficacy (Fig. <a href="#Fig5" class="usa-link">5M</a>). These findings offer new perspectives and potential therapeutic strategies for OC immunotherapy, potentially improving patient outcomes and treatment efficacy.</p></section><section id="Sec29"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (28.4KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM2_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 1</a><sup> (2.9MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM3_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 2</a><sup> (2.7MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM4_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 3</a><sup> (2.8MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM5"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM5_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 4</a><sup> (2.3MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM6"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM6_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 5</a><sup> (4.6MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM7"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM7_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 6</a><sup> (9MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM8"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 1</a><sup> (9.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM9"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM9_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 2</a><sup> (10KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM10"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM10_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 3</a><sup> (11.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM11"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM11_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 4</a><sup> (11.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM12"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM12_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Original Western Blot Images</a><sup> (22MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank the Department of Biobank of Shanghai First Maternity and Infant Hospital, for providing OC tissues.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>J Shen carried out the experiments at the animal and cell levels; F Xu obtained the ethics, collected all the ovarian cancer samples and carried out the experiments at the organoid; T Liu and Y Ye carried out the Luciferase-GFP-SKOV3/HEY cells and the cell killing assay; J Shen analyzed all the data and took the lead in writing and revising the manuscript. S Xu supervised this study. All the authors provided critical feedback on shaping the research, analysis, and manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was supported by the National Natural Science Foundation of China (81772762 to SX), the Natural Science Foundation of Shanghai (21ZR1450900 to SX), and the Shanghai Science and Technology Planning Project (21Y11907000 to SX).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data and computer code analyzed in this research are available from the corresponding author on reasonable request. Original western blots images are provided in Supplementary Materials.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par62">The authors declare no competing interests.</p></section><section id="FPar2"><h2 class="pmc_sec_title">Ethical approval</h2>
<p id="Par63">Human subjects were obtained from the Department of Biobank of Shanghai First Maternity and Infant Hospital, Tongji University. Informed consent had been previously obtained from all corresponding patients. All experiments involving human subjects were approved by the Ethics Committee of Shanghai First Maternity and Infant Hospital (Ethics Committee number: KS2142). All experiments involving animal subjects were approved by the Ethics Committee of Tongji University (Ethics Committee number: TJBG01721101).</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>Edited by Hans-Uwe Simon</p></div>
<div class="fn p" id="fn2"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
</div></section><section id="sec30"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41419-025-07939-9.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.
</cite> [<a href="https://doi.org/10.3322/caac.21660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33538338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sung%20H,%20Ferlay%20J,%20Siegel%20RL,%20Laversanne%20M,%20Soerjomataram%20I,%20Jemal%20A,%20et%20al.%20Global%20Cancer%20Statistics%202020:%20GLOBOCAN%20Estimates%20of%20Incidence%20and%20Mortality%20Worldwide%20for%2036%20Cancers%20in%20185%20Countries.%20CA%20Cancer%20J%20Clin.%202021;71:209%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Wilson MK, Pujade-Lauraine E, Aoki D, Mirza MR, Lorusso D, Oza AM, et al. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease. Ann Oncol. 2017;28:727–32.
</cite> [<a href="https://doi.org/10.1093/annonc/mdw663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6246494/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27993805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilson%20MK,%20Pujade-Lauraine%20E,%20Aoki%20D,%20Mirza%20MR,%20Lorusso%20D,%20Oza%20AM,%20et%20al.%20Fifth%20Ovarian%20Cancer%20Consensus%20Conference%20of%20the%20Gynecologic%20Cancer%20InterGroup:%20recurrent%20disease.%20Ann%20Oncol.%202017;28:727%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Prat J, D’Angelo E, Espinosa I. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. Hum Pathol. 2018;80:11–27.
</cite> [<a href="https://doi.org/10.1016/j.humpath.2018.06.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29944973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prat%20J,%20D%E2%80%99Angelo%20E,%20Espinosa%20I.%20Ovarian%20carcinomas:%20at%20least%20five%20different%20diseases%20with%20distinct%20histological%20features%20and%20molecular%20genetics.%20Hum%20Pathol.%202018;80:11%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, et al. Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer. J Clin Oncol. 2015;33:4015–22.
</cite> [<a href="https://doi.org/10.1200/JCO.2015.62.3397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26351349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hamanishi%20J,%20Mandai%20M,%20Ikeda%20T,%20Minami%20M,%20Kawaguchi%20A,%20Murayama%20T,%20et%20al.%20Safety%20and%20Antitumor%20Activity%20of%20Anti-PD-1%20Antibody,%20Nivolumab,%20in%20Patients%20With%20Platinum-Resistant%20Ovarian%20Cancer.%20J%20Clin%20Oncol.%202015;33:4015%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Matulonis UA, Shapira-Frommer R, Santin AD, Lisyanskaya AS, Pignata S, Vergote I, et al. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Ann Oncol. 2019;30:1080–7.
</cite> [<a href="https://doi.org/10.1093/annonc/mdz135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31046082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matulonis%20UA,%20Shapira-Frommer%20R,%20Santin%20AD,%20Lisyanskaya%20AS,%20Pignata%20S,%20Vergote%20I,%20et%20al.%20Antitumor%20activity%20and%20safety%20of%20pembrolizumab%20in%20patients%20with%20advanced%20recurrent%20ovarian%20cancer:%20results%20from%20the%20phase%20II%20KEYNOTE-100%20study.%20Ann%20Oncol.%202019;30:1080%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11:889–96.
</cite> [<a href="https://doi.org/10.1038/ni.1937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20856220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Biswas%20SK,%20Mantovani%20A.%20Macrophage%20plasticity%20and%20interaction%20with%20lymphocyte%20subsets:%20cancer%20as%20a%20paradigm.%20Nat%20Immunol.%202010;11:889%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Wanderley CW, Colon DF, Luiz JPM, Oliveira FF, Viacava PR, Leite CA, et al. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner. Cancer Res. 2018;78:5891–900.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-17-3480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30104241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wanderley%20CW,%20Colon%20DF,%20Luiz%20JPM,%20Oliveira%20FF,%20Viacava%20PR,%20Leite%20CA,%20et%20al.%20Paclitaxel%20Reduces%20Tumor%20Growth%20by%20Reprogramming%20Tumor-Associated%20Macrophages%20to%20an%20M1%20Profile%20in%20a%20TLR4-Dependent%20Manner.%20Cancer%20Res.%202018;78:5891%E2%80%93900." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Qi Z, Xu Z, Zhang L, Zou Y, Li J, Yan W, et al. Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kalpha/beta/delta treatment. Nat Commun. 2022;13:182.
</cite> [<a href="https://doi.org/10.1038/s41467-021-27833-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8748754/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35013322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qi%20Z,%20Xu%20Z,%20Zhang%20L,%20Zou%20Y,%20Li%20J,%20Yan%20W,%20et%20al.%20Overcoming%20resistance%20to%20immune%20checkpoint%20therapy%20in%20PTEN-null%20prostate%20cancer%20by%20intermittent%20anti-PI3Kalpha/beta/delta%20treatment.%20Nat%20Commun.%202022;13:182." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Tsuji T, Matsuzaki J, Odunsi K. Tissue residency of memory CD8(+) T cells matters in shaping immunogenicity of ovarian cancer. Cancer Cell. 2022;40:452–4.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2022.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11778921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35537410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsuji%20T,%20Matsuzaki%20J,%20Odunsi%20K.%20Tissue%20residency%20of%20memory%20CD8(+)%20T%20cells%20matters%20in%20shaping%20immunogenicity%20of%20ovarian%20cancer.%20Cancer%20Cell.%202022;40:452%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>An X, Zhu Y, Zheng T, Wang G, Zhang M, Li J, et al. An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer. Mol Ther Nucleic Acids. 2019;14:80–89.
</cite> [<a href="https://doi.org/10.1016/j.omtn.2018.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6305687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30583098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?An%20X,%20Zhu%20Y,%20Zheng%20T,%20Wang%20G,%20Zhang%20M,%20Li%20J,%20et%20al.%20An%20Analysis%20of%20the%20Expression%20and%20Association%20with%20Immune%20Cell%20Infiltration%20of%20the%20cGAS/STING%20Pathway%20in%20Pan-Cancer.%20Mol%20Ther%20Nucleic%20Acids.%202019;14:80%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Wu J, Dobbs N, Yang K, Yan N. Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion. Immunity. 2020;53:115–26.e5.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2020.06.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7365768/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32640258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20J,%20Dobbs%20N,%20Yang%20K,%20Yan%20N.%20Interferon-Independent%20Activities%20of%20Mammalian%20STING%20Mediate%20Antiviral%20Response%20and%20Tumor%20Immune%20Evasion.%20Immunity.%202020;53:115%E2%80%9326.e5." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Domvri K, Petanidis S, Zarogoulidis P, Anestakis D, Tsavlis D, Bai C, et al. Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis. Clin Immunol. 2021;222:108620.
</cite> [<a href="https://doi.org/10.1016/j.clim.2020.108620" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33176208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Domvri%20K,%20Petanidis%20S,%20Zarogoulidis%20P,%20Anestakis%20D,%20Tsavlis%20D,%20Bai%20C,%20et%20al.%20Treg-dependent%20immunosuppression%20triggers%20effector%20T%20cell%20dysfunction%20via%20the%20STING/ILC2%20axis.%20Clin%20Immunol.%202021;222:108620." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.
</cite> [<a href="https://doi.org/10.1186/s12943-021-01316-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7863491/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33546704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia%20L,%20Oyang%20L,%20Lin%20J,%20Tan%20S,%20Han%20Y,%20Wu%20N,%20et%20al.%20The%20cancer%20metabolic%20reprogramming%20and%20immune%20response.%20Mol%20Cancer.%202021;20:28." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Corrado M, Pearce EL. Targeting memory T cell metabolism to improve immunity. J Clin Invest. 2022;132:e148546.
</cite> [<a href="https://doi.org/10.1172/JCI148546" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8718135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34981777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corrado%20M,%20Pearce%20EL.%20Targeting%20memory%20T%20cell%20metabolism%20to%20improve%20immunity.%20J%20Clin%20Invest.%202022;132:e148546." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Chini CCS, Peclat TR, Gomez LS, Zeidler JD, Warner GM, Kashyap S, et al. Dihydronicotinamide Riboside Is a Potent NAD(+) Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages. Front Immunol. 2022;13:840246.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.840246" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8913500/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35281060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chini%20CCS,%20Peclat%20TR,%20Gomez%20LS,%20Zeidler%20JD,%20Warner%20GM,%20Kashyap%20S,%20et%20al.%20Dihydronicotinamide%20Riboside%20Is%20a%20Potent%20NAD(+)%20Precursor%20Promoting%20a%20Pro-Inflammatory%20Phenotype%20in%20Macrophages.%20Front%20Immunol.%202022;13:840246." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Guo X, Tan S, Wang T, Sun R, Li S, Tian P, et al. NAD + salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity. Hepatology. 2023;78:468–85.
</cite> [<a href="https://doi.org/10.1002/hep.32658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35815363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20X,%20Tan%20S,%20Wang%20T,%20Sun%20R,%20Li%20S,%20Tian%20P,%20et%20al.%20NAD%20+%20salvage%20governs%20mitochondrial%20metabolism,%20invigorating%20natural%20killer%20cell%20antitumor%20immunity.%20Hepatology.%202023;78:468%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Almeida L, Dhillon-LaBrooy A, Carriche G, Berod L, Sparwasser T. CD4(+) T-cell differentiation and function: Unifying glycolysis, fatty acid oxidation, polyamines NAD mitochondria. J Allergy Clin Immunol. 2021;148:16–32.
</cite> [<a href="https://doi.org/10.1016/j.jaci.2021.03.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33966898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Almeida%20L,%20Dhillon-LaBrooy%20A,%20Carriche%20G,%20Berod%20L,%20Sparwasser%20T.%20CD4(+)%20T-cell%20differentiation%20and%20function:%20Unifying%20glycolysis,%20fatty%20acid%20oxidation,%20polyamines%20NAD%20mitochondria.%20J%20Allergy%20Clin%20Immunol.%202021;148:16%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Yang M, Wang B, Hou W, Zeng H, He W, Zhang XK, et al. NAD(+) metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer. J Immunother Cancer. 2024;12:e009281.
</cite> [<a href="https://doi.org/10.1136/jitc-2024-009281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11284830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39067875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20M,%20Wang%20B,%20Hou%20W,%20Zeng%20H,%20He%20W,%20Zhang%20XK,%20et%20al.%20NAD(+)%20metabolism%20enzyme%20NNMT%20in%20cancer-associated%20fibroblasts%20drives%20tumor%20progression%20and%20resistance%20to%20immunotherapy%20by%20modulating%20macrophages%20in%20urothelial%20bladder%20cancer.%20J%20Immunother%20Cancer.%202024;12:e009281." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Hippen AA, Omran DK, Weber LM, Jung E, Drapkin R, Doherty JA, et al. Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factors. Genome Biol. 2023;24:239.
</cite> [<a href="https://doi.org/10.1186/s13059-023-03077-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10588129/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37864274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hippen%20AA,%20Omran%20DK,%20Weber%20LM,%20Jung%20E,%20Drapkin%20R,%20Doherty%20JA,%20et%20al.%20Performance%20of%20computational%20algorithms%20to%20deconvolve%20heterogeneous%20bulk%20ovarian%20tumor%20tissue%20depends%20on%20experimental%20factors.%20Genome%20Biol.%202023;24:239." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zou C, Shen J, Xu F, Ye Y, Wu Y, Xu S. Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis. J Cancer. 2024;15:3510–30.
</cite> [<a href="https://doi.org/10.7150/jca.94616" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11134437/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38817865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zou%20C,%20Shen%20J,%20Xu%20F,%20Ye%20Y,%20Wu%20Y,%20Xu%20S.%20Immunoreactive%20Microenvironment%20Modulator%20GBP5%20Suppresses%20Ovarian%20Cancer%20Progression%20by%20Inducing%20Canonical%20Pyroptosis.%20J%20Cancer.%202024;15:3510%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Kopper O, de Witte CJ, Lohmussaar K, Valle-Inclan JE, Hami N, Kester L, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 2019;25:838–49.
</cite> [<a href="https://doi.org/10.1038/s41591-019-0422-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31011202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kopper%20O,%20de%20Witte%20CJ,%20Lohmussaar%20K,%20Valle-Inclan%20JE,%20Hami%20N,%20Kester%20L,%20et%20al.%20An%20organoid%20platform%20for%20ovarian%20cancer%20captures%20intra-%20and%20interpatient%20heterogeneity.%20Nat%20Med.%202019;25:838%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B, et al. Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models. Stem Cell Rep. 2020;14:717–29.</cite> [<a href="https://doi.org/10.1016/j.stemcr.2020.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7160357/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32243841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maenhoudt%20N,%20Defraye%20C,%20Boretto%20M,%20Jan%20Z,%20Heremans%20R,%20Boeckx%20B,%20et%20al.%20Developing%20Organoids%20from%20Ovarian%20Cancer%20as%20Experimental%20and%20Preclinical%20Models.%20Stem%20Cell%20Rep.%202020;14:717%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Benskey MJ, Manfredsson FP. Lentivirus Production and Purification. Methods Mol Biol. 2016;1382:107–14.
</cite> [<a href="https://doi.org/10.1007/978-1-4939-3271-9_8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26611582/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Benskey%20MJ,%20Manfredsson%20FP.%20Lentivirus%20Production%20and%20Purification.%20Methods%20Mol%20Biol.%202016;1382:107%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Shen J, Liu T, Lv J, Xu S. Identification of an Immune-Related Prognostic Gene CLEC5A Based on Immune Microenvironment and Risk Modeling of Ovarian Cancer. Front Cell Dev Biol. 2021;9:746932.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.746932" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8547616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34712666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20J,%20Liu%20T,%20Lv%20J,%20Xu%20S.%20Identification%20of%20an%20Immune-Related%20Prognostic%20Gene%20CLEC5A%20Based%20on%20Immune%20Microenvironment%20and%20Risk%20Modeling%20of%20Ovarian%20Cancer.%20Front%20Cell%20Dev%20Biol.%202021;9:746932." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Shen J, Liu T, Bei Q, Xu S. Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis. Front Oncol. 2021;11:685065.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.685065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8247482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34222009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20J,%20Liu%20T,%20Bei%20Q,%20Xu%20S.%20Comprehensive%20Landscape%20of%20Ovarian%20Cancer%20Immune%20Microenvironment%20Based%20on%20Integrated%20Multi-Omics%20Analysis.%20Front%20Oncol.%202021;11:685065." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Grozio A, Mills KF, Yoshino J, Bruzzone S, Sociali G, Tokizane K, et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab. 2019;1:47–57.
</cite> [<a href="https://doi.org/10.1038/s42255-018-0009-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6530925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grozio%20A,%20Mills%20KF,%20Yoshino%20J,%20Bruzzone%20S,%20Sociali%20G,%20Tokizane%20K,%20et%20al.%20Slc12a8%20is%20a%20nicotinamide%20mononucleotide%20transporter.%20Nat%20Metab.%202019;1:47%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Zhang Z, Zhang C. Regulation of cGAS-STING signalling and its diversity of cellular outcomes. Nat Rev Immunol. 2025;25:425–44.
</cite> [<a href="https://doi.org/10.1038/s41577-024-01112-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39774812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Z,%20Zhang%20C.%20Regulation%20of%20cGAS-STING%20signalling%20and%20its%20diversity%20of%20cellular%20outcomes.%20Nat%20Rev%20Immunol.%202025;25:425%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Zhang X, Bai XC, Chen ZJ. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway. Immunity. 2020;53:43–53.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2020.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32668227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20X,%20Bai%20XC,%20Chen%20ZJ.%20Structures%20and%20Mechanisms%20in%20the%20cGAS-STING%20Innate%20Immunity%20Pathway.%20Immunity.%202020;53:43%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Steiner A, Hrovat-Schaale K, Prigione I, Yu CH, Laohamonthonkul P, Harapas CR, et al. Deficiency in coatomer complex I causes aberrant activation of STING signalling. Nat Commun. 2022;13:2321.
</cite> [<a href="https://doi.org/10.1038/s41467-022-29946-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9051092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35484149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Steiner%20A,%20Hrovat-Schaale%20K,%20Prigione%20I,%20Yu%20CH,%20Laohamonthonkul%20P,%20Harapas%20CR,%20et%20al.%20Deficiency%20in%20coatomer%20complex%20I%20causes%20aberrant%20activation%20of%20STING%20signalling.%20Nat%20Commun.%202022;13:2321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Ma W, Goldberg J. Rules for the recognition of dilysine retrieval motifs by coatomer. EMBO J. 2013;32:926–37.
</cite> [<a href="https://doi.org/10.1038/emboj.2013.41" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3616288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23481256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20W,%20Goldberg%20J.%20Rules%20for%20the%20recognition%20of%20dilysine%20retrieval%20motifs%20by%20coatomer.%20EMBO%20J.%202013;32:926%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Mukai K, Ogawa E, Uematsu R, Kuchitsu Y, Kiku F, Uemura T, et al. Homeostatic regulation of STING by retrograde membrane traffic to the ER. Nat Commun. 2021;12:61.
</cite> [<a href="https://doi.org/10.1038/s41467-020-20234-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7782846/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33397928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mukai%20K,%20Ogawa%20E,%20Uematsu%20R,%20Kuchitsu%20Y,%20Kiku%20F,%20Uemura%20T,%20et%20al.%20Homeostatic%20regulation%20of%20STING%20by%20retrograde%20membrane%20traffic%20to%20the%20ER.%20Nat%20Commun.%202021;12:61." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Deng Z, Chong Z, Law CS, Mukai K, Ho FO, Martinu T, et al. A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome. J Exp Med. 2020;217:e20201045.
</cite> [<a href="https://doi.org/10.1084/jem.20201045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7596814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32725126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng%20Z,%20Chong%20Z,%20Law%20CS,%20Mukai%20K,%20Ho%20FO,%20Martinu%20T,%20et%20al.%20A%20defect%20in%20COPI-mediated%20transport%20of%20STING%20causes%20immune%20dysregulation%20in%20COPA%20syndrome.%20J%20Exp%20Med.%202020;217:e20201045." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Corrales L, Matson V, Flood B, Spranger S, Gajewski TF. Innate immune signaling and regulation in cancer immunotherapy. Cell Res. 2017;27:96–108.
</cite> [<a href="https://doi.org/10.1038/cr.2016.149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5223230/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27981969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corrales%20L,%20Matson%20V,%20Flood%20B,%20Spranger%20S,%20Gajewski%20TF.%20Innate%20immune%20signaling%20and%20regulation%20in%20cancer%20immunotherapy.%20Cell%20Res.%202017;27:96%E2%80%93108." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. Immunity. 2018;49:754–63.e4.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2018.09.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6488306/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30332631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marcus%20A,%20Mao%20AJ,%20Lensink-Vasan%20M,%20Wang%20L,%20Vance%20RE,%20Raulet%20DH.%20Tumor-Derived%20cGAMP%20Triggers%20a%20STING-Mediated%20Interferon%20Response%20in%20Non-tumor%20Cells%20to%20Activate%20the%20NK%20Cell%20Response.%20Immunity.%202018;49:754%E2%80%9363.e4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917–21.
</cite> [<a href="https://doi.org/10.1038/nature03445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15829967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Farmer%20H,%20McCabe%20N,%20Lord%20CJ,%20Tutt%20AN,%20Johnson%20DA,%20Richardson%20TB,%20et%20al.%20Targeting%20the%20DNA%20repair%20defect%20in%20BRCA%20mutant%20cells%20as%20a%20therapeutic%20strategy.%20Nature.%202005;434:917%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Shen J, Zhao W, Ju Z, Wang L, Peng Y, Labrie M, et al. PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness. Cancer Res. 2019;79:311–9.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-18-1003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6588002/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30482774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20J,%20Zhao%20W,%20Ju%20Z,%20Wang%20L,%20Peng%20Y,%20Labrie%20M,%20et%20al.%20PARPi%20Triggers%20the%20STING-Dependent%20Immune%20Response%20and%20Enhances%20the%20Therapeutic%20Efficacy%20of%20Immune%20Checkpoint%20Blockade%20Independent%20of%20BRCAness.%20Cancer%20Res.%202019;79:311%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Cassetta L, Pollard JW. A timeline of tumour-associated macrophage biology. Nat Rev Cancer. 2023;23:238–57.
</cite> [<a href="https://doi.org/10.1038/s41568-022-00547-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36792751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cassetta%20L,%20Pollard%20JW.%20A%20timeline%20of%20tumour-associated%20macrophage%20biology.%20Nat%20Rev%20Cancer.%202023;23:238%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Hoekstra ME, Slagter M, Urbanus J, Toebes M, Slingerland N, de Rink I. et al. Distinct spatiotemporal dynamics of CD8(+) T cell-derived cytokines in the tumor microenvironment. Cancer Cell. 2024;42:157–67.e9.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2023.12.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10783802/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38194914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hoekstra%20ME,%20Slagter%20M,%20Urbanus%20J,%20Toebes%20M,%20Slingerland%20N,%20de%20Rink%20I.%20et%20al.%20Distinct%20spatiotemporal%20dynamics%20of%20CD8(+)%20T%20cell-derived%20cytokines%20in%20the%20tumor%20microenvironment.%20Cancer%20Cell.%202024;42:157%E2%80%9367.e9." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22:119–41.
</cite> [<a href="https://doi.org/10.1038/s41580-020-00313-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7963035/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33353981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Covarrubias%20AJ,%20Perrone%20R,%20Grozio%20A,%20Verdin%20E.%20NAD(+)%20metabolism%20and%20its%20roles%20in%20cellular%20processes%20during%20ageing.%20Nat%20Rev%20Mol%20Cell%20Biol.%202021;22:119%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells?. Trends Biochem Sci. 2016;41:211–8.
</cite> [<a href="https://doi.org/10.1016/j.tibs.2015.12.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4783224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26778478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liberti%20MV,%20Locasale%20JW.%20The%20Warburg%20Effect:%20How%20Does%20it%20Benefit%20Cancer%20Cells?.%20Trends%20Biochem%20Sci.%202016;41:211%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Minhas PS, Liu L, Moon PK, Joshi AU, Dove C, Mhatre S, et al. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nat Immunol. 2019;20:50–63.
</cite> [<a href="https://doi.org/10.1038/s41590-018-0255-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6768398/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30478397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Minhas%20PS,%20Liu%20L,%20Moon%20PK,%20Joshi%20AU,%20Dove%20C,%20Mhatre%20S,%20et%20al.%20Macrophage%20de%20novo%20NAD(+)%20synthesis%20specifies%20immune%20function%20in%20aging%20and%20inflammation.%20Nat%20Immunol.%202019;20:50%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Fang J, Hou P, Liu S, Zuo M, Liu Z, Chen W, et al. NAD(+) salvage governs the immunosuppressive capacity of mesenchymal stem cells. Cell Mol Immunol. 2023;20:1171–85.
</cite> [<a href="https://doi.org/10.1038/s41423-023-01073-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10541442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37580400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fang%20J,%20Hou%20P,%20Liu%20S,%20Zuo%20M,%20Liu%20Z,%20Chen%20W,%20et%20al.%20NAD(+)%20salvage%20governs%20the%20immunosuppressive%20capacity%20of%20mesenchymal%20stem%20cells.%20Cell%20Mol%20Immunol.%202023;20:1171%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Franssen LE, Mutis T, Lokhorst HM, van de Donk N. Immunotherapy in myeloma: how far have we come?. Ther Adv Hematol. 2019;10:2040620718822660.
</cite> [<a href="https://doi.org/10.1177/2040620718822660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6348514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30719268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Franssen%20LE,%20Mutis%20T,%20Lokhorst%20HM,%20van%20de%20Donk%20N.%20Immunotherapy%20in%20myeloma:%20how%20far%20have%20we%20come?.%20Ther%20Adv%20Hematol.%202019;10:2040620718822660." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Garcia-Canaveras JC, Heo D, Trefely S, Leferovich J, Xu C, Philipson BI, et al. CAR T-Cells Depend on the Coupling of NADH Oxidation with ATP Production. Cells 2021;10:2334.</cite> [<a href="https://doi.org/10.3390/cells10092334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8472053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34571983/" class="usa-link">PubMed</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Wang Y, Wang F, Wang L, Qiu S, Yao Y, Yan C, et al. NAD(+) supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells. Cell Rep. 2021;36:109516.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2021.109516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34380043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Wang%20F,%20Wang%20L,%20Qiu%20S,%20Yao%20Y,%20Yan%20C,%20et%20al.%20NAD(+)%20supplement%20potentiates%20tumor-killing%20function%20by%20rescuing%20defective%20TUB-mediated%20NAMPT%20transcription%20in%20tumor-infiltrated%20T%20cells.%20Cell%20Rep.%202021;36:109516." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Shi X, Jiang Y, Kitano A, Hu T, Murdaugh RL, Li Y, et al. Nuclear NAD(+) homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells. Sci Adv. 2021;7:eabf3895.</cite> [<a href="https://doi.org/10.1126/sciadv.abf3895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8294764/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34290089/" class="usa-link">PubMed</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Nacarelli T, Lau L, Fukumoto T, Zundell J, Fatkhutdinov N, Wu S, et al. NAD(+) metabolism governs the proinflammatory senescence-associated secretome. Nat Cell Biol. 2019;21:397–407.
</cite> [<a href="https://doi.org/10.1038/s41556-019-0287-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6448588/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30778219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nacarelli%20T,%20Lau%20L,%20Fukumoto%20T,%20Zundell%20J,%20Fatkhutdinov%20N,%20Wu%20S,%20et%20al.%20NAD(+)%20metabolism%20governs%20the%20proinflammatory%20senescence-associated%20secretome.%20Nat%20Cell%20Biol.%202019;21:397%E2%80%93407." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Zhang M, Cui J, Chen H, Wang Y, Kuai X, Sun S, et al. High-Dosage NMN Promotes Ferroptosis to Suppress Lung Adenocarcinoma Growth through the NAM-Mediated SIRT1-AMPK-ACC Pathway. Cancers (Basel) 2023;15:2427.</cite> [<a href="https://doi.org/10.3390/cancers15092427" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10177531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37173894/" class="usa-link">PubMed</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Mackenzie KJ, Carroll P, Martin CA, Murina O, Fluteau A, Simpson DJ, et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature. 2017;548:461–5.
</cite> [<a href="https://doi.org/10.1038/nature23449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5870830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28738408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mackenzie%20KJ,%20Carroll%20P,%20Martin%20CA,%20Murina%20O,%20Fluteau%20A,%20Simpson%20DJ,%20et%20al.%20cGAS%20surveillance%20of%20micronuclei%20links%20genome%20instability%20to%20innate%20immunity.%20Nature.%202017;548:461%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Walker MM, Crute BW, Cambier JC, Getahun A. B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses. J Immunol. 2018;201:2641–53.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1701405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6497520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30282750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walker%20MM,%20Crute%20BW,%20Cambier%20JC,%20Getahun%20A.%20B%20Cell-Intrinsic%20STING%20Signaling%20Triggers%20Cell%20Activation,%20Synergizes%20with%20B%20Cell%20Receptor%20Signals,%20and%20Promotes%20Antibody%20Responses.%20J%20Immunol.%202018;201:2641%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Imanishi T, Unno M, Kobayashi W, Yoneda N, Matsuda S, Ikeda K, et al. Reciprocal regulation of STING and TCR signaling by mTORC1 for T-cell activation and function. Life Sci Alliance 2019;2:e201800282.</cite> [<a href="https://doi.org/10.26508/lsa.201800282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6348487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30683688/" class="usa-link">PubMed</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Li W, Lu L, Lu J, Wang X, Yang C, Jin J, et al. cGAS-STING-mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy. Sci Transl Med. 2020;12:eaay9013.</cite> [<a href="https://doi.org/10.1126/scitranslmed.aay9013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32581136/" class="usa-link">PubMed</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, et al. NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer’s disease via cGAS-STING. Proc Natl Acad Sci. USA 2021, 118.</cite> [<a href="https://doi.org/10.1073/pnas.2011226118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8449423/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34497121/" class="usa-link">PubMed</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Myakala K, Wang XX, Shults NV, Krawczyk E, Jones BA, Yang X, et al. NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease. J Biol Chem. 2023;299:104975.
</cite> [<a href="https://doi.org/10.1016/j.jbc.2023.104975" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10413283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37429506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Myakala%20K,%20Wang%20XX,%20Shults%20NV,%20Krawczyk%20E,%20Jones%20BA,%20Yang%20X,%20et%20al.%20NAD%20metabolism%20modulates%20inflammation%20and%20mitochondria%20function%20in%20diabetic%20kidney%20disease.%20J%20Biol%20Chem.%202023;299:104975." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97–101.
</cite> [<a href="https://doi.org/10.1038/nature12347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23803760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yoshimoto%20S,%20Loo%20TM,%20Atarashi%20K,%20Kanda%20H,%20Sato%20S,%20Oyadomari%20S,%20et%20al.%20Obesity-induced%20gut%20microbial%20metabolite%20promotes%20liver%20cancer%20through%20senescence%20secretome.%20Nature.%202013;499:97%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347:aaa2630.
</cite> [<a href="https://doi.org/10.1126/science.aaa2630" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25636800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20S,%20Cai%20X,%20Wu%20J,%20Cong%20Q,%20Chen%20X,%20Li%20T,%20et%20al.%20Phosphorylation%20of%20innate%20immune%20adaptor%20proteins%20MAVS,%20STING,%20and%20TRIF%20induces%20IRF3%20activation.%20Science.%202015;347:aaa2630." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Li DJ, Sun SJ, Fu JT, Ouyang SX, Zhao QJ, Su L, et al. NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin. Theranostics. 2021;11:4381–402.
</cite> [<a href="https://doi.org/10.7150/thno.53652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7977447/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33754067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20DJ,%20Sun%20SJ,%20Fu%20JT,%20Ouyang%20SX,%20Zhao%20QJ,%20Su%20L,%20et%20al.%20NAD(+)-boosting%20therapy%20alleviates%20nonalcoholic%20fatty%20liver%20disease%20via%20stimulating%20a%20novel%20exerkine%20Fndc5/irisin.%20Theranostics.%202021;11:4381%E2%80%93402." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Jiang Y, Wang Y, Chen G, Sun F, Wu Q, Huang Q. et al. Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer. Cell Metab. 2024;36:1806–22.e11.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2024.05.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38897198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20Y,%20Wang%20Y,%20Chen%20G,%20Sun%20F,%20Wu%20Q,%20Huang%20Q.%20et%20al.%20Nicotinamide%20metabolism%20face-off%20between%20macrophages%20and%20fibroblasts%20manipulates%20the%20microenvironment%20in%20gastric%20cancer.%20Cell%20Metab.%202024;36:1806%E2%80%9322.e11." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Wu Q, Cheng Z, Zhu J, Xu W, Peng X, Chen C. et al. Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line. Sci Rep. 2015;5:9520.
</cite> [<a href="https://doi.org/10.1038/srep09520" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4379480/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25825284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20Q,%20Cheng%20Z,%20Zhu%20J,%20Xu%20W,%20Peng%20X,%20Chen%20C.%20et%20al.%20Suberoylanilide%20hydroxamic%20acid%20treatment%20reveals%20crosstalks%20among%20proteome,%20ubiquitylome%20and%20acetylome%20in%20non-small%20cell%20lung%20cancer%20A549%20cell%20line.%20Sci%20Rep.%202015;5:9520." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>She J, Sheng R, Qin ZH. Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors. Aging Dis. 2021;12:1879–97.
</cite> [<a href="https://doi.org/10.14336/AD.2021.0523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8612620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34881075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?She%20J,%20Sheng%20R,%20Qin%20ZH.%20Pharmacology%20and%20Potential%20Implications%20of%20Nicotinamide%20Adenine%20Dinucleotide%20Precursors.%20Aging%20Dis.%202021;12:1879%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Menon RM, Gonzalez MA, Adams MH, Tolbert DS, Leu JH, Cefali EA. Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites. J Clin Pharm. 2007;47:681–8.</cite> [<a href="https://doi.org/10.1177/0091270007300264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17463214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Menon%20RM,%20Gonzalez%20MA,%20Adams%20MH,%20Tolbert%20DS,%20Leu%20JH,%20Cefali%20EA.%20Effect%20of%20the%20rate%20of%20niacin%20administration%20on%20the%20plasma%20and%20urine%20pharmacokinetics%20of%20niacin%20and%20its%20metabolites.%20J%20Clin%20Pharm.%202007;47:681%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Lin X, Gupta D, Vaitsiankova A, Bhandari SK, Leung KSK, Menolfi D. et al. Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts. Mol Cell. 2024;84:3916–31.e7.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2024.09.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11615737/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39383878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20X,%20Gupta%20D,%20Vaitsiankova%20A,%20Bhandari%20SK,%20Leung%20KSK,%20Menolfi%20D.%20et%20al.%20Inactive%20Parp2%20causes%20Tp53-dependent%20lethal%20anemia%20by%20blocking%20replication-associated%20nick%20ligation%20in%20erythroblasts.%20Mol%20Cell.%202024;84:3916%E2%80%9331.e7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, et al. Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer. Clin Cancer Res. 2023;29:2800–7.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-22-2444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11934101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37097611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wethington%20SL,%20Shah%20PD,%20Martin%20L,%20Tanyi%20JL,%20Latif%20N,%20Morgan%20M,%20et%20al.%20Combination%20ATR%20(ceralasertib)%20and%20PARP%20(olaparib)%20Inhibitor%20(CAPRI)%20Trial%20in%20Acquired%20PARP%20Inhibitor-Resistant%20Homologous%20Recombination-Deficient%20Ovarian%20Cancer.%20Clin%20Cancer%20Res.%202023;29:2800%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Li J, Zhang C, Hu Y, Peng J, Feng Q, Hu X. Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia. Br J Haematol. 2024;205:2432–41.
</cite> [<a href="https://doi.org/10.1111/bjh.19820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39406393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Zhang%20C,%20Hu%20Y,%20Peng%20J,%20Feng%20Q,%20Hu%20X.%20Nicotinamide%20enhances%20Treg%20differentiation%20by%20promoting%20Foxp3%20acetylation%20in%20immune%20thrombocytopenia.%20Br%20J%20Haematol.%202024;205:2432%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (28.4KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM2_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 1</a><sup> (2.9MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM3_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 2</a><sup> (2.7MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM4_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 3</a><sup> (2.8MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM5_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 4</a><sup> (2.3MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM6_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 5</a><sup> (4.6MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM7_ESM.tif" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Figure 6</a><sup> (9MB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 1</a><sup> (9.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material9_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM9_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 2</a><sup> (10KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material10_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM10_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 3</a><sup> (11.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material11_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM11_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Table 4</a><sup> (11.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material12_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373823/bin/41419_2025_7939_MOESM12_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Original Western Blot Images</a><sup> (22MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data and computer code analyzed in this research are available from the corresponding author on reasonable request. Original western blots images are provided in Supplementary Materials.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cell Death &amp; Disease are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41419-025-07939-9"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41419_2025_Article_7939.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (6.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373823/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373823/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373823%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373823/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373823/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373823/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846839/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373823/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846839/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373823/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373823/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="yVREtE8Rc8HIUtDm1cNAUVxh375IIYtRTPtJAw6h07An2XATXBrh2AICfoj09H0o">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
